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1I. GENERAL INTRODUCTION
The various sections of this Thesis all relate to the 
identification of synaptic transmitters within the mammal­
ian central nervous system. Several authors have proposed 
criteria that a substance needs to satisfy for it to be 
regarded as a transmitter within the central nervous system 
( Paton, 1958; Curtis, 1961; Costa and Bloom, 1965;
Werman, 1966; Bradley, 1968 ; Curtis and Johnston, 1970) . 
Those listed below are those of Curtis and Johnston (1970) .
(a) The substance and the enzymes for its synthesis should 
be present in the appropriate nerve endings.
(b) The substance should be released following impulses in 
the appropriate nerve fibres.
(c) The postsynaptic action of the substance should be 
identical with that of the transmitter.
(d) Compounds which block synaptic transmission by a speci­
fic postsynaptic effect must also antagonize the action of 
the suspected transmitter.
(e) The processes which inactivate and remove released 
tranmitter should also terminate the action of the arti­
ficially administered substance.
Transmitter identification thus depends on a body of 
neurochemical, neurophysiological and anatomical evidence 
which collectively, but not separately, points to a sub­
stance being a transmitter. The various sections of this 
Thesis contain data relevant to a possible excitatory 
transmitter role for L-glutamate and L-aspartate and an 
inhibitory transmitter role for glycine and gamma-amino­
butyric acid.
The sections on morphine (IV), strychnine (VI) and 
bicuculline (VII) all relate to criterion (d), that sub­
stances which block transmission should also block the
2action of transmitter suspects.
The work on organic mercurials and the action of amino 
acids (V) is relevant to criterion (e) which deals with the 
inactivation of transmitters, although attempts to influence 
synaptic events with the mercurials were unsuccessful.
The section dealing with glutamate levels in spinal 
ganglia, roots and peripheral nerves (VIII) is directed 
towards criterion (a), that the transmitter suspect be pre­
sent within the appropriate neurones, whilst that on the 
sensitivity of spinal neurones to L-glutamate and L-aspar- 




The preparation of the spinal cord for extracellular 
recording of action potentials, and the electrophoretic 
application of substances to neurones were common to most 
sections of this Thesis.
( i ) Microelectrophoresi s
This technique consists of the administration of 
compounds to the extracellular environment of single 
nerve cells by ejecting ions from glass micropipettes. 
The methods used were those described by Curtis (1964) . 
Five and seven barrel micropipettes were drawn in a 
vertical microelectrode puller and broken back to the 
desired size (commonly 5-7yM) by striking their tips 
with a fine glass rod, the movements of which were 
controlled by a "joystick" micromanipulator. The 
solutions to be used were centrifuged, then trans­
ferred to the barrels of the micropipettes, and driven 
to the tips by further centrifugation. The barrels 
were then inspected microscopically and the electrical 
resistance of each measured.
The centre barrel of each micropipette was filled 
with 4M NaCl, and electrical contact made with this 
solution with a Ag-AgCl wire. Contact with drug 
solutions was made using silver wires. The resistance 
of each barrel with the electrode in the tissue under 
study was measured by determining the current required 
to establish 0.5 V potential difference across the 
solution. The polarity of this retaining voltage 
was such as to retain the active ion within the micro­
pipette, and the retaining current was maintained 
throughout the experiment to retard outward diffusion
4of the active substance. The magnitudes of currents
-9used are expressed in nano amps {nA, 10 A) , a current 
which ejected cations from a micropipette being called 
cationic (+), an anionic (-) current that ejecting 
anions. A current of O nA indicates removal of the 
retaining current from a barrel, thus allowing diffus- 
ional efflux of a compound; with potent compounds, 
this was often sufficient to produce measurable effects. 
(il) The recording of action potentials extracellularly 
A cathode follower first stage with provision for 
capacitance neutralisation was followed by two pre­
amplifier units (time constant .003 sec) and an 
oscilloscope. The output of the cathode follower was 
also connect.' . to another amplifying system, the out­
put of which was used to trigger a pulse generator.
A voltage discriminator was used to select the size of 
action potentials which triggered this generator, the 
output pulses of which were fed to a ratemeter and to 
an oscilloscope for monitoring. The output of the 
ratemeter was connected to a rectilinear pen recorder 
thus providing a continuous display of the firing rate 
of the cell being studied.
(iii) The feline spinal cord preparation
Following the induction of anaesthesia, the left ex­
ternal radial vein, the R common carotid artery and 
the trachea were cannulated. The animal's temperature 
was maintained between 36-38°C by heating pads placed 
under the abdomen and chest. The current through 
these pads was controlled by a solid state regulating 
unit, the temperature sensitive probe of which was 
placed between the rib cage and R scapula.
The laminae of all lumbar vertebrae were removed, 
and the spinal cord divided at the lower thoracic level
5after infiltration with 1% procaine solution. The 
dural sac was opened dor sally over the lumbar and 
sacral cord and, if Renshaw cells were being sought, 
the seventh lumbar and first sacral ventral roots 
were divided at the inter vertebral foramen and moun­
ted on platinum electrodes. Volleys entering the 
spinal cord were monitored by a platinum ball elec­
trode placed on the dorsal columns. The indifferent 
electrode, a coil of chlorided silver wire enclosed in 
gauze, was sutured to the vertebral muscles. The 
spinal cord was immersed in liquid paraffin (BP), a 
pool being formed by the raising and anchoring of skin 
flaps. Small areas of pia were removed with fine for­
ceps at the sites of proposed electrode penetration.
(b ) The sensitivity of spinal interneurones to L-glutamate 
and L-aspartate.
The solutions used were:
L-Aspartate 1.0 M pH 7 NaOH 
L-Glutamate 1.0 M pH 7 NaOH 
DL-Homocysteic acid 0.2 M pH 8 NaOH 
Acetylcholine chloride i.OM 
Cats were anaesthetised with pentobarbitone sodium 
(35 mg/kg initially, and supplemented when necessary) 
and the spinal cord was prepared for recording. The 
left sural, common peroneal and common tibial nerves 
were dissected, mounted on platinum electrodes, and 
were stimulated at a strength three to five times 
threshold. Renshaw cells were identified by responses 
which followed antidromic stimulation of ventral roots.
Interneurones and Renshaw cells of the left seventh 
lumbar segment (L7) were studied. The micropipette 
was manoeuvered with a micromanipulator which permitted 
controlled movement in 3 axes (Eccles, Fatt, Landgren
6and Winsbury, 1954). The sensitivity of these cells 
to excitant amino acids was assessed in the following 
manner .
The cell was initially excited with a range of 
amino acid concentrations (ejecting currents) , and a 
rough potency assessed for each substance on the basis 
of the ratio of ejecting currents. A firing rate 
which was easily maintained by each substance was then 
selected, and the currents of each required to attain 
this firing rate were determined. This, idealised 
method was disturbed by the following factors.
(1) The cell could not be fired by one substance with 
the currents that could be passed through the particu­
lar micropipette.
(2) The cell did not maintain a constant firing rate, 
but the rate "faded" with continued ejection of an ex­
citant. This was most common with L-glutamate.
(3) The cell spike became positive before any constant 
firing rate was attained. This "depolarisation block" 
did not prevent gross comparisons of potency being 
made, if the other compound was scarcely active with 
the same current.
After the necessary data were obtained from each 
cell, the following measurements were taken, using the 
micromanipulator where appropriate, in order to map the 
position of neurones within the spinal cord.
(1) The distance between the midline and the most 
medial point of entry of the dorsal roots.
(2) The angle between the microelectrode and the 
micromanipulator vertical.
(3) The angle between an implanted fine steel needle 
and a line drawn through the dorsal and ventral fissures 
of a section of the spinal cord. This latter line is
7the "mapping vertical" and usually differed from true 
vertical, as indicated by the micromanipulator, as a 
result of slight twisting of the vertebrae by the fixa­
tion clamps. All microelectrode tracks were then 
corrected for this error.
(4) The distance from the point of entry of the micro­
electrode into the spinal cord and the midline.
(5) The depth of each cell from the surface, measured 
along its particular track.
(6) The maximal antero-posterior thickness of the 
cord.
For each animal the cells studied were plotted on 
a standard map drawn from a section taken from upper L7. 
The ratio
distance from microelectrode entry point to midline, 
distance between line of dorsal root entry and midline
determined the point from which each electrode track 
was drawn at a known angle to the "mapping vertical"
The standard map was divided into 1320 squares by 
grid lines, there being 45 lines drawn in an antero­
posterior direction and 31 in a mediolateral direction. 
Cells were thus given coordinates. These coordinates 
together with other variables measured were encoded on 
punch cards. A computer program was written which 
printed out a map of the spinal cord together with 
the number of cells in different positions which met 
certain requirements. Up to six requirements could 
be nominated to be met by a cell for it to be included 
in a map.
Using these methods only two plotted cells were 
located in the white matter. On several tracks the 
electrode passed through dorsal horn, lateral funi­
culus and then ventral horn, and cells judged physio­
logically to be close to the junction of grey and
8white matter, when plotted, appeared in the expected 
location.
(c) Morphine, glycine and spinal reflexes
(i) Microelectrophoretic experiments 
The solutions used were:
Morphine sulphate - 70 mM in H^O 
Strychnine HC1 - 2 mM in 165 mM NaCl 
Glycine 0.5 M pH 3 HC1
Y-Aminobutyric acid (GABA) 0.5M pH 3 HC1 
DL-Homocysteate 0.2 M pH 7, NaOH 
Acetylcholine chloride 1.0 M
(ii) Reflex experiments
Monosynaptic reflexes were recorded peripherally 
from muscle nerves in response to supramaximal elec­
trical stimulation (1/sec) of the transected left 
seventh lumbar and first sacral dorsal roots. The 
reflexes were usually stabilized by a preceding sub- 
maximal stimulus which facilitated the response to a 
second vo1ley.
Inhibitory curves were ..plotted directly on an 
X-Y recorder (Varian F 80 - converted to a point plott
er). The X voltage was proportional to the interval 
between the testing and the inhibiting volley, the Y 
voltage being proportional to the area of the mono- 
phasic reflex response. This area was measured using 
a voltage to frequency converter (Vidar 260) and a 
gated counter with analogue output (Hewlett Packard 
counter 5214L, Digital Recorder H23-562A).
Direct Inhibition. Curves were plotted of the in­
hibition of the monosynaptic reflex recorded from the 
posterior biceps semitendinosus muscle nerve (BST) by 
volleys in the ipsilateral quadriceps nerve (Q), stimu 
lated at twice threshold intensity.
9Recurrent Inhibition. Curves were plotted of the 
inhibition of the monosynaptic reflex recorded from 
either the lateral or medial gastrocnemius nerve (LG,
MG) by supramaximal stimulation of the other, dorsal 
roots having been transected. This inhibition was 
often increased by adding other hind limb nerves to 
the branch providing the inhibitory volley.
Both types of inhibition were studied in each 
animal. This necessitated leaving L6 dorsal root 
intact because of its content of quadriceps fibres.
As the muscle nerves used to study recurrent inhibition 
may have contained afferent fibres which entered the 
spinal cord via the L6 dorsal root, one animal was 
prepared in the usual way, but recurrent inhibition was 
also studied on the opposite (right) side with all dor­
sal roots (L6 to S3 inclusive) transected.
(iii) Morphine and the inhibition of Renshaw cells
Renshaw cells were inhbiited by squeezing the 
hindpaw with a modified bicycle wheel rim brake. An 
adjustable stop was incorporated in the handle of this 
brake to fix the separation of the jaws, when fully 
applied, at any desired distance. The inhibition of 
firing produced in this way was commonly reproduceable 
to within + 2 0%.
(iv) Morphine and the activation of Renshaw cells by dorsal 
and ventral root stimuli
In animals anaesthetised with pentobarbitone, Ren­
shaw cells were rarely activated by dorsal root stimuli, 
and hence most studies were performed with animals de­
cerebrated by coagulation of the brain stem under halo- 
thane anaesthesia (Crawford and Curtis, 1964) , the 
anaesthetic then being withdrawn.
The responses of each cell to a maximal ventral
10
root stimulus, were recorded on film, ten sweeps being 
superimposed. When using submaximal ventral root 
stimuli and dorsal root stimuli, individual responses 
were recorded on moving film and averaged arithmetically. 
Latencies were measured from the arrival of the ventral 
root volley at the spinal cord. To obtain any accuracy 
in these measurements, it was necessary to expand the 
sweep, with the result that only the first six to eight 
spikes of a ventral root response were included in the 
records. The first action potential was often obscured 
by the field potential resulting from the antidromic 
firing of motoneurones and hence its latency could rarely 
be measured accurately.
In one experiment, a computer (Enhancetron, Nuclear 
Data), was used to prepare a post stimulus histogram of 
cell firing in response to submaximal ventral root 
stimuli. Only the first three action potentials were 
recorded in this way.
(d) The potentiation of amino acid excitation and depression
by organic mercurials and thiosemicarbazide
(i) Organic mercurials
The following solutions were used:
p-Chloromercuriphenylsulphonate Na salt (pCS), lOmM in 
16 5mM NaC1, pH 8-8.5 
Glycine 0.5M pH 3 (HCl)
GABA 0.5M pH 3 (HCl)
D-a-Alanine 0.5M pH 3 (HCl)
L-d-Alanine 0.5 M, pH 3 (HCl)
DL-homocysteate Na 0.2M (DLH)
L-Glutamate 1.0M pH 8 NaOH 
D-Glutamate 1.0M pH 8 NaOH 
L-Aspartate 1.0 M pH 8 NaOH 
Acetylcholine chloride 1.0M
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Cells were studied in the seventh lumbar and first 
sacral segments of the spinal cords of cats anaesthe­
tised with pentobarbitone. In studying the effect of 
impulses in hindpaw afferent fibres on Renshaw cell 
firing, the dissection was modified by replacing the 
clamp that normally held the left hind limb by a sling, 
to prevent damage to the nerves of the foot.
In assessing possible potentiation of one compound 
by another the following difficulties were avoided as 
far as possible.
(1) If the distance between the drug-containing pipette 
and the cell decreases after control observations have 
been made, drug responses will appear to be enhanced.
Such an effect can be minimized by moving the electrode 
in order to keep the spike amplitude constant, and to 
maintain a constant response to another substance whose 
action is unaffected by the potentiating agent. This 
latter manoeuvre may not be always possible and depends 
on the specificity of the potentiating substance.
(2) When a compound has not been ejected for some 
time, its concentration within the tip of the micro­
pipette will be lower than elsewhere in the barrel be­
cause of the retaining current# the drug being diluted 
by the ions from the external medium. Subsequent 
ejecting currents will eject increasing amounts of the 
drug as the concentration within the tip approaches 
that of the bulk of the solution and unless time is 
allowed for the tip concentration to reach this constant 
level, an apparent weakening of the action of the com­
pound will be observed. Once equilibrium conditions are 
reached, this error can be minimized by ejecting the 
compound for a fixed time at fixed time intervals.
(3) Any change in the excitability of the cell after
12
control observations have been made may introduce 
errors in estimating the effectiveness of a compound.
This was a minor problem with the organic mercurials, 
but the increase is basal firing rate following sys­
temic injection of thiosemicarbazide was significant.
By studying a cell which required the continuous ejec­
tion of an excitant, a constant firing rate could be 
maintained by varying the ejecting current of this 
excitant.
Thiosemicarbazide
This compound was injected intravenously using a 
20mg/ml aqueous solution. Extracellularly recorded 
action potentials were photographed to permit direct 
and accurate measurements of the time between the ter­
mination of the current ejecting a drug and the resump­
tion of the control level of cell firing. Quantitative 
studies on changes in the effectiveness of excitant and 
depressant amino acids require that the basal level of 
firing be constant, as changes in this alone will pro­
duce apparent changes in the action of these substances. 
An increase in the basal frequency tends to prolong the 
action of excitants and makes the measurement of re­
covery times less precise.
Because of the tendency of thiosemicarbazide to 
increase the spontaneous firing rate of neurones, cells 
were studied which required the continuous ejection of 
an excitant to produce a satisfactory basal level of 
firing in the control period. Adjustment of the amount 
of the excitant ejected after thiosemicarbazide, enabled 
a constant basal firing rate to be maintained.
(e) The specificity of strychnine as a glycine antagonist
in the spinal cord.
The solutions used were:
13
Glycine 0.5M, pH 3, HCl 
GABA 0.5M, pH 3, HCl 
DLH 0.2M pH 8, NaOH 
Acetylcholine chloride 1.0M.
Strychnine HCl 2mM or 10 mM in 165 mM NaCl 
Experiments were performed on spinal interneurones 
and Renshaw cells of the lower lumbar segments of cats. 
The majority of animals were anaesthetised with pento­
barbitone sodium (35 mg/kg intraperitoneally, initially); 
some animals were decerebrated by coagulation of the 
brain stem under halothane anaesthetic (Crawford and 
Curtis, 1966) and were unanaesthetised during the ex­
periment .
In studying antagonism of one compound by another, 
the same precautions needed in observing potentiation 
and outlined previously when considering organic mer­
curials, were taken. Sufficient time was allowed for 
the effects of each administered compound to be observed 
under equilibrium conditons. Care was taken to main­
tain a constant basal firing rate before and during the 
action of strychnine, as a given dose of a depressant 
produced less percentage depression as the basal firing 
rate rose.
(f) Bicuculline GABA and Central Inhibition
Bicuculline hydrochloride is sparingly soluble in 
water. Solutions were prepared in 165 mM NaCl at pH 3, 
and are estimated to have a concentration of the alka­
loid not greater than 5 m M . Hence, assuming equal 
transport numbers for Na+ and bicuculline, approximately 
one thirtieth of a cationic current passed from these 
solutions consisted of bicuculline ions. Difficulties 
were experiences in ejecting bicuculline with currents 
greater than 100 nA owing to unpredictable rises in
14
electrical resistance. These presumably resulted 
from the reduced solubility of bicuculline in tissue
fluids at a pH of 7.4, the solubility of this alkaloid
-4in water at this pH being less than 3 x 10 M.
The solutions used intravenously contained 0.2 
mg/ml of the base.
The multibarrel micropipettes used in the spinal 
cord and thalamus were of 5-7 yM tip diameter. Those 
used in Deiters' nucleus were 7-9 PM as the cells of 
this nucleus are large (C.120y) and commonly required 
relatively high electrophoretic currents to produce 
measurable effects. The animals were anaesthetised 
with pentobarbitone and a bilateral pheumothorax per­
formed for experiments on the thalamus and Deiters 
nucleus.
Deiters1 Nucleus
The approach to Deiters' nucleus was that described 
by Ito, Hongo, Yoshida, Okada and Obata (1964). The 
pharynx and oesophagus were divided at C3 level and 
reflected cranially to expose the basiocciput, a flap 
of which was removed, exposing the lower pons and medulla. 
The animals head was ventroflexed 20° so that the elec­
trode, when introduced approximately 5 mm caudal to the 
pontomedullary junction, avoided the inferior cerebellar 
artery. The ventral spinal cord was exposed by partial 
removal of the intervertebral disc between C3 and C4 
vertebral bodies; this exposure through the disk was 
chosen because the anterior dural sinuses of the spinal 
cord are maximally separated at this site. A bipolar 
stimulating electrode was placed on the ventral surface 
of the spinal cord to stimulate the ventral spinocere­
bellar tract so activating Deiters neurones antidromi- 
cally. Coaxial needle electrodes were placed stereo-
15
taxically in lobules II, III and IV of the ipsilateral 
cerebellar vermis 2mm from the midline, and cemented 
with dental acrylic to a perspex plate rigidly attached 
to the skull and stereotaxic head frame.
Thaiamus
Thalamic neurones were approached stereotaxically, 
the overlying cerebral tissue being removed by suction 
and the exposed tissues continually irrigated with a 
carbogenated mammalian Ringer solution at 37 °C. The 
contralateral ulnar, superficial radial, median, tibial 
and peroneal nerves were prepared for electrical stimu­
lation, so enabling neurones of the ventralis postero- 
lateralis (VPL) and ventralis postero medialis (VPM) 
thalamic nuclei to be activated. Thalamocortical re­
lay neurones were identified as those excited with short 
latency (4-5 msec for the fore limb, 8-10 msec for the 
hind limb) by impulses in only one of the peripheral 
nerves.
(g ) Free amino acids in spinal roots, dorsal root ganglia
and peripheral nerves 
(l) Cat
The chemical procedures in these studies were performed 
by Dr. G.A.R. Johnston of this department. Dorsal 
root ganglia and ventral roots were obtained from the 
upper sacral and lower lumbar spinal segments of mature 
cats (4 to 5 kg) anaesthetised with pentobarbitone 
sodium (35 mg/kg initially, supplemented when necessary). 
That part of the dorsal roots between ganglia and spinal 
cord was bisected, and the half distal to the cord ana­
lysed separately from that proximal to the cord. The 
segment of dorsal root peripheral to the ganglion was 
comparatively short and decussation of dorsal and vent­
ral root fibres occurred almost immediately after their
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union. Care was taken to minimise ventral root con­
tamination of this segment. Samples of gastrocnemius 
and sural nerve were obtained from the left hind limb 
and samples of radial nerve from the right fore limb.
The specimens were rinsed in Ringer solution, 
blotted, frozen in liquid nitrogen and stored at -28° 
for not more than one week before extraction of free 
amino acids. The specimens were weighed while still 
frozen and not less than 18 mg used for each extraction. 
Each specimen was homogenised in a Potter-E1vehjem 
homogeniser (glass mortar and Teflon pestle) in 2 ml of 
ice-cold 1% aqueous picric acid and allowed to stand 
at o° for 30 min. Dowex 2 x 10 (Cl form) resin,
200-400 mesh, was added portionwise to the homogenate 
sufficient to discharge the yellow colour in the solu­
tion. The resin was filtered off with Whatman No. 1 
paper, washed with 2 x 10 ml of 0.02 N-hydrochloric 
acid and the combined filtrate and washings evaporated 
to dryness below 40° in vacuo on a rotatory evaporator. 
The residue was dissolved in a known volume of pH 2.2 
citrate buffer, filtered, and an aliquot of the filt­
rate analysed for acidic and neutral amino acids on a 
Technicon Auto Analyser (modified by Mr. L.B. James, 
Department of Biochemistry; optimum sensitivity range 
0.01 to 0.10 ymole, accuracy +_3% within this range) 
using the two buffer system of Spackman, Moore and 
Stein (1958). The size of each aliquot analysed was 
such that the concentrations of alanine and glycine each 
exceeded 0.01 ymole. Several samples of extracts from 
both dorsal and ventral roots were analysed completely 
by the single column procedure of Hamilton (1963) . 
Concentrations were expressed as ymole/g wet tissue.
( ii) Dog and rat
All animals were anaesthetised with pentobarbitone Na.
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That part of the dorsal root between ganglion and spinal 
cord was sampled in all species. In the cat and rat 
this part is almost wholly intradural whereas in the 
dog there are approximately equal intra and extra dural 
segments. These segments in the dog were analysed 
separately. Tissues were taken from lower lumbar and 
upper sacral spinal cord segments.
18
III. THE SENSITIVITY OF SPINAL INTERNEURONES TO 
L-GLUTAMATE AND L-ASPARTATE
Neurochemical studies by Graham, Shank, Werman and 
Aprison (1967) of the distribution of L-glutamate and L-as- 
partate in the feline spinal cord have shown that L-gluta- 
mate is present in greatest amounts in the dorsal grey 
matter and the highest levels of L-aspartate occur in the 
ventral grey matter. The authors believe these levels to 
be consistent with L-glutamate and L-aspartate operating 
as excitatory transmitters at the terminals of primary aff­
erent fibres and spinal excitatory interneurones respectively.
In the original studies of the action of acidic amino 
acids which excite spinal neurones (Curtis and Watkins,
1961, 1963) , L-glutamate and L-aspartate were rated as being of
approximately equal potency as excitants of both Renshaw 
cells and other spinal interneurones. In the cerebral cor­
tex, L-glutamate was reported to be more potent than L-asp- 
artate (Krnjevic and Phillis, 1961, 1963) , but other workers 
found them to be roughly equipotent (Crawford and Curtis,
1964). These two amino acids have proved to be excitants 
of all cells tested in the brain of the cat (reviewed by 
Curtis and Crawford, 1969) .
McLennan, Huffman and Marshall (1968) found that of 
cells of the nucleus ventralis lateralis of the thalamus, 
those in the zone of projection of the superior cerebellar 
peduncle were more sensitive to L-glutamate and acetylcholine 
than others, all neurones being uniformly sensitive to DL- 
homocysteate and DL-N-methylaspartate. Sensitivity to an 
excitant was measured on the basis of the minimum electro­
phoretic current required to excite a particular neurone.
These studies led to the suggestion that L-glutamate and 
acetylcholine are excitatory transmitters in this region of 
the tha1amus.
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Such conclusions, however, are based on several assumptions. 
Firstly it is assumed that these excitants act only on the 
postsynaptic membrane, and not on intervening areas of cell 
membrane or presynaptic structures. Whilst there is evi­
dence that this is true for the action of L-glutamate and 
GABA on insect and crustacean muscle (Usherwood, Machili and 
Leaf, 1968; Takeuchi and Takeuchi, 1967) the situation for
mammalian central neurones remains unknown, although first 
order sensory cells of the lamprey (functionally equivalent 
to dorsal root ganglion cells of other vertebrates), which 
have no synapses, are unresponsive to GABA and L-glutamate 
administered electrophoretically (Martin, Wickelgren and 
Beranek, 1970). It is also assumed that the substances 
used are not structural analogues of the transmitter, cap­
able of combining with the latter's receptor and producing 
a re spon s e .
Absolute sensitivity is of no use in inferring a 
transmitter role for a substance. For example Renshaw 
cells whilst being very sensitive to acetylcholine, the 
likely transmitter released at motoneurone axon collaterals, 
are more sensitive to a number of cholinomimetics which do 
not occur in the central nervous system (Curtis and Ryall, 
1966a).
Studies of relative sensitivity however, can provide 
evidence for a transmitter role if differences in sensivity 
can be correlated with some other difference between the 
groups of cells being studied, for example in afferent 
connections. Thus Renshaw cells are excited by A C h , yet 
dorsal horn interneurones are not (Curtis and Eccles, 1958).
In these studies cell sensitivity was measured by the 
ratio of the electrophoretic currents of L-aspartate and 
L-glutamate which produced equal responses, and it was hoped 
to correlate differences with :-
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(a) The neurochemical studies of Graham et a1 . (1967)
(b) The paucity of primary afferent fibre connections to 
Renshaw cells when compared with other spinal inter­
neurones, as judged by the long latency of activation 
of Renshaw cells by stimulating dorsal roots (Curtis, 
Phillis and Watkins, 1961) , group III fibres in ipsi- 
lateral nerves (Eccles, Fatt and Koketsu, 1954) or 
high threshold afferents in contralateral nerves (Wil­
son, Talbot and Kato, 1964; Wilson, 1966).
In terms of these factors, Renshaw cells might be re­
latively less sensitive to glutamate and more sensitive to 




Data were obtained from 176 cells, thirty one of which 
were Renshaw cells and the remainder interneurones. Many 
computer compiled maps of the spinal cord were obtained from 








The distribution of all interneurones 
The distribution of all Renshaw cells
Fig . 3 The distribution of interneurones more 
sitive to asparate than to glutamate
sen-
Fig . 4 The distribution of interneurones more 
sitive to glutamate than to aspartate
sen-
Fig . 5 The distribution of interneurones equally 
sensitive to aspartate and to glutamate
Fig . 6 The distribution of Renshaw cells more 




The distribution of Renshaw cells more sen­
sitive to glutamate than to aspartate, 
seen that the distribution of interneurones
investigated within the spinal cord bears no relation to 
sensitivity to the two amino acids (Figs. 3, 4, 5) . In all
three categories of sensitivity the cells were evenly dis­
tributed throughout the areas of spinal cord studied. How­
ever with Renshaw cells, a significantly higher proportion 
were more sensitive to aspartate when compared with other 
interneurones. These proportions are listed in Table 1.
In few cases however was any one compound more than 
twice as potent as the other as shown in Table 2.
In no case was either L-glutamate or L-aspartate more 
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N o . with 
L-asp .
No. with No. with Not re- Total
L-Glut. L-Asp. corded
more pot- more pot- equipotent
ent than 
L-Glut.
ent than with L-Glut.
L-Asp.
Renshaw




30 28 6 145
Total 105 31 31 9 176
X 2 = 22.2264 P< .001
Table 2 :
Interneurones Potency ratio 1 to 2 Potency ratio >2
Aspartate>Glutamate 73 8






If a cell is more sensitive, as defined in Methods, to 
a substance A than to a substance B, both being administered 
e l e c t r o p h o r e t i c a l l y , any one or combination of the following 
factors could be the cause, assuming of course that equal 
currents eject A and B at approximately equal rates.
(1) A diffuses more freely than B, and can affect a greater 
area of the cell.
(2) A is not removed as readily as B from the extracellular  
environment, and can diffuse to a greater area of the 
cell or attain a higher conce n t r a t i o n  over the same 
area.
(3) There are more receptors of the A type than of the B 
type within a given area.
(4) A is of a higher intrinsic activity (Ariens and Simonis, 
1964) at its receptor than is B at its receptor.
(5) A can react with both type A and type B receptors whereas 
B cannot.
(6) Type A receptors are in general closer to the a d m i n i s ­
tering m icropipette than are those of type B.
If B is then found to be more potent than A on another 
cell, the differences in cell sens itivity could be due to : -
(1) The second cell has a higher p r o p o r t i o n  of type B r e ­
ceptors than the first within the volume of tissue 
affected by ejected substances. This could be the r e ­
sult of a higher number of B receptors pr esent uniformly 
over the cell, or the type B receptors being closer to 
the micropipette.
(2) Either substance has a different intrinsic activity on 
dif ferent cell types. This implies a change in the 
r e c e p t o r .
(3) Either A or B is removed at a different rate from the
environment of different cells.
If it is assumed that these compounds act only on syna­
pses and that the cells being studied are of roughly uni­
form size and shape, then differences in sensitivity to dif­
ferent compounds could reasonably be interpreted in terms of 
relative proportions of the different synapses.
Given all these assumptions, the results obtained for 
Renshaw cells and interneurones can be interpreted as sugges­
ting that Renshaw cells have a higher proportion of synapses 
at which aspartate is a tranmitter than interneurones. In 
contrast interneurones appear to have more synapses at which 
glutamate operates as an excitatory transmitter. Hence 
these findings are consistent with the hypothesis of Graham 
et al . ( 1967) , that glutamate is the transmitter released
from primary afferent terminals and aspartate is that re­
leased by spinal interneurones.
However, in only two of 24 Renshaw cells in which aspar­
tate was more potent than glutamate was the potency ratio 
greater than two. Interpreting this in terms of number of 
synapses implies that, whilst there may be few primary affer­
ent connections with Renshaw cells there is a significant 
proportion from other sources at which glutamate is released. 
This brings out another weakness in studies of this nature - 
the relative proportions of synapses from various sources 
onto any one cell type of the mammalian central nervous sys­
tem are not known with any accuracy and hence comparisons 
between these proportions and sensitivity to transmitter 
suspects can only be made in a very gross manner, even allow­
ing the assumptions above.
Low potency ratios could result from both L-aspartate 
and L-glutamate acting at the receptor for each substance, 
as these compounds are structurally similar, differing only 
in the length of the carbon atom chain separating two carb­
oxyl groups. Such an interaction would not necessarily
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impair the normal operation of synapses as, to be signifi­
cant, it would require the escape of transmitter from the 
synaptic cleft. With a substance applied microelectro- 
phoretically however, it would mask differences in the pro­
portions of receptors between cell groups as judged by sen­
sitivity ratios.
These potency ratios however, are similar to those 
observed by McLennan et al. (1968) in the VL nucleus of the 
thalamus. In a delineated zone, cells were approximately 
twice as sensitive to L-glutamate when compared with other 
areas, whilst sensitivity to DLH and N-methylaspartate re­
mained unchanged. These authors discuss "specific gluta­
mate receptors" in addition to "non specific receptors" in 
the zone of increased sensitivity. An alternative explana­
tion is that glutamate is a widely used excitatory trans­
mitter in the brain and increased sensitivity reflects an 
increase in the afferent connections of this type.
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IV. MORPHINE, GLYCINE AND SPINAL INHIBITION
Morphine is structurally similar to thebaine, having 
hydroxyl groups instead of methoxy groups at positions 3 
and 6 of the molecule as shown in Fig. 8. Thebaine is a 
convulsant, and blocks postsynaptic inhibition of spinal 
motoneurones by impulses in spinal afferent fibres (Fatt, 
1954; Longo and Chiavarelli, 1962). Furthermore, thebaine 
reduces the inhibitory action of glycine on spinal neurones 
(Curtis, Hosli, and Johnston, 1968b), but is much weaker than 
strychnine in this respect. Morphine is also a convulsant 
in the cat (McGuigan and Ross, 1915; Wikler 1944), and hence 
it was of interest to assess this substance as a potential 
glycine antagonist.
The literature concerning morphine and its action on 
spinal reflexes is not consistent with that of a purely 
strychnine-like agent. Kruglov (1964) found that intra­
venous morphine in doses of 5-10 mg/kg reduced the recurrent 
inhibition of motoneurones, but either had no effect on, or 
enhanced, the inhibition of motoneurones by impulses in 
group IA afferents (direct inhibition). Both of these in­
hibitions are strychnine sensitive (Eccles, 1957). Felpel, 
Sinclair and Yim (1968; 1970), confirmed the findings of
Kruglov (1964), and found that the total number of action 
potentials synaptically evoked in Renshaw cells by a maximal 
ventral root stimulus was not altered during the phase of 
reduced recurrent inhibition. It thus seemed unlikely that 
morphine reduced recurrent inhibition by disturbing the 
cholinergic synaptic excitation of Renshaw cells. They 
suggested that morphine may interfere with the operation of 
the inhibitory synapse mediating recurrent inhibition, with­
out affecting that of direct inhibition, but could not ex­
clude hypoxia consequent upon respiratory depression as the 
basis of the reduction in recurrent inhibition.
THEBAINE MORPHINE
Fig. 8
■Rie structures of thebaine and morphine
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Since morphine proved to be a glycine anta gonist when 
a d mi ni st ered near spinal neurones, it became apparent that 
these observations of the effect of morphine on spinal i n ­
hib itions were important to the status of glycine as a 
spinal inhibitory transmitter. Hence the reflex e x p e r i ­
ments were re-investigated. As a further test of glycine 
as a spinal inhibitory transmitter, the effect of electro- 
p h or et ic ally a d m i n istered morphine on the inhibition of Ren- 
shaw cells by impulses p r o duced in hind limb nerves by 
squeezing the hind paw (Wilson, Talbot and Kato, 1964) was 
examined. This inhibition can be reduced by strychnine 
adm ini st ered both s y stemically (Wilson and Talbot, 1963) and 
el ec t r o p h o r e t i c a l l y  (Biscoe and C u r t i s , 1966) , and hence it 
is possib le that a glycine like amino acid (Curtis et a l . , 
1968a) is the tran smitter at the final inhibitory synapse.
Although the findings of Felpel et a l . , (1970) would
seem to exclude an interference by morphine with the a c t i ­
vation of Renshaw cells by impulses in ventral roots as a 
basis for the suscep t i b i l i t y  of recurrent inhibition to 
morphine, Biscoe and Curtis ( u n p u b l i s h e d ) , had previously 
noted that e l e c t r o p h o r e t i c a l l y  a d m i n i s t e r e d  mo rphine p r o ­
longed the latencies of the initial action pote ntials of a 
Renshaw cell in response to a ventral root stimulus. This 
can be interpreted as resulting from an interference by 
morphine with the release of acetylcholine from the t e r m i n ­
als of moto neurone axon collaterals, a process which has 
been observed in other tissues.
Morphine has been re ported to
(a) Reduce the a c e t y l choline output of p o s t - g a n g l i o n i c  
fibres innervating the guinea pig ileum (Paton, 1957; 
Schaumann, 1957) .
(b) Reduce the N wave (synaptic wave) in the isolated s u p e r ­
ior cervical ga nglion of the rabbit in which t r a n s ­
mis sion had been blocked with hexamethoniurn (Kosterlitz
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and Wallis, 1966) , and reduce the acetycholine output 
of the perfused superior cervical ganglion of the cat 
(Kosterlitz, Lees and Watt, 1969).
(c) Increase the total acetycholine in the brain of the rat 
(Giarman and Pepeu, 1962; Large and Milton, 1970) and 
mouse (Hano, Kaneto, Kakunaga and Moribayashi, 1964) .
(d) Reduce the output of acetylcholine in the artificially 
perfused cerebral ventricles of cats, in response to 
neostigmine (Beleslin and Polak, 1965).
(e) Reduce the uptake of carbachol and decamethonium by
slices of cat cerebral cortex (Taylor, Creese and Tzu 
Chiau, 1969) .
14(f) Reduce the release of C -acetylcholine from rat brain 
slices on the addition of KC1 (Sharkawi and Schulman, 
1969) .
(g) Reduce the slowing of the rabbit heart in response to 
vagal stimulation in the absence of changes of the re­
sponse to administered acetylcholine (Kennedy and West, 
1967) .
The effect of electrophoretically administered morphine 
on the activation of Renshaw cells was re-examined using 
stimuli delivered to both dorsal and ventral roots. There 
is evidence that the firing of a Renshaw cells in response 
to a dorsal root stimulus is usually mediated by a non-chol- 
inergic synapse, being of longer latency than that produced 
by a ventral root stimulus (Eccles, Fatt and Koketsu 1954a; 
Curtis, Phillis and Watkins, 1961) and being reduced by di­
hydro-3 -erythroidine in only a small proportion of cases 
(Curtis, Phillis and Watkins, 1961) . Curtis and Ryall 
(1966b) concluded that the usual response of a Renshaw cell 
to a dorsal root stimulus is probably unrelated to the dis­
charge of motoneurones and is mediated by a non-cho1inergic 
synapse.
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Hence if morphine does interflere specifically with 
the release of acetylcholine from nerve terminals, differ­
ences would be expected in its effects on the firing of 
Renshaw cells by impulses in dorsal and ventral roots.
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RESULTS
(i) E 1ectrophoretically administered morphine and glycine
Morphine was a reversible antagonist of the action of
glycine but, with the concentrations used, was without 
effect on the action of GABA on spinal neurones. With both 
Renshaw cells and spinal interneurones morphine appeared to 
be approximately thirty times less potent than strychnine as 
a glycine antagonist. Morphine had no effect on the exci­
tant action of acetylcholine or DLH. Results from one cell 
are illustrated in Fig. 9. This interneurone was fired by 
the continuous ejection of DLH (5 nA). There was signifi­
cant depression of the firing rate by removal of the currents 
retaining glycine (O n A , solid horizontal bar) or GABA (bro­
ken horizontal bar) within the micropipette. Morphine,
10 nA for 90 sec, completely suppressed the action of glycine, 
but that of GABA was unaffected. Restoration of glycine 
action occurred within 1 minute of terminating the adminis­
tration of morphine.
(ii) Morphine and spinal inhibition
Morphine given intravenously in a dose of the order 
10 mg/kg had catastrophic effects on blood pressure and 
respiration, but when small doses were given initially, the 
circulatory effects of subsequent large doses were minimized 
(Schmidt and Livingstone, 1933). In the initial experi­
ments, the first dose of morphine given was 5-10 mg/kg.
During the ensuing period of circulatory collapse, direct 
inhibition was unchanged whilst recurrent inhibition was 
reduced or abolished. In one animal this effect on re­
current inhibition was reversible, recovering as the blood 
pressure returned to normal.
Administration of morphine in small divided doses, to 
minimize circulatory disturbances, resulted in a roughly 
parallel diminution in both direct and recurrent inhibition,
A 40 GLYCINE GABA —
MORPHINE 10 n A
20 -  
0  -
Fig. 9
The effect of electrophoretically administered 
morphine on the depression of a spinal interneurone by 
glycine and GABA.
Glycine (0 nA, solid horizontal line) and GABA 
(0 nA, broken horizontal line) were ejected alternately.
A, before; B, during; and C, immediately after the 
ejection of morphine (lO nA, thick horizontal line). 
Morphine ejection commenced 90 secs, before the record
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Fig. 10
The effects on blood pressure (a ), direct and 
recurrent inhibition (b ) and surface potentials generated 
by Renshaw cell activity (c) of morphine administered 
intravenously to a cat in divided doses. The doses (mg/kg) 
are indicated by the numbers and arrows between A and B.
A. Blood pressure, the vertial lines indicate systolic 
diastolic pressure. B. Maximum inhibition of mon o ­
synaptic reflexes; filled circles - recurrent inhibition 
of medial gastrocnemius motoneurones by volleys in lateral 
gastrocnemius and tibial n e r v e s , filled triangles - direct 
inhibition of biceps-semitendinosus motoneurones by 
volleys in quadriceps nerve. C. Potentials recorded 
from the surface of the L6 segment in response to supra­
maximal stimulation of the L 6 ventral root at the times 
indicated by the arrows. A b s c i s s a e ; A,B, minutes, C msec.
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as illustrated in Fig. 10. The blood pressure of the ani­
mal is plotted in Fig. 10 A, the length of the lines repre­
senting pulse pressure. In Fig. 10 B, percentage inhibition 
is plotted against time, for both direct (triangles) and re­
current (circles) inhibition. The doses of morphine, and 
times of administration, are indicated by arrows between A 
and B. The records of Fig. 10 C are potentials recorded 
from the surface of the spinal cord in response to ventral 
root stimulation, the waves being generated by the summed 
activity of many Renshaw cells.
In confirmation of Kruglov (1964), the direct inhibi­
tion studied was initially increased with low doses of mor­
phine (up to 5 mg/kg), and was then reduced in parallel with 
recurrent inhibition, which was decreased in a roughly linear 
fashion with increasing doses of morphine. Seven experi­
ments were performed in which both direct and recurrent in­
hibition were studied, and all gave similar results. In 
three experiments direct inhibition alone was studied, and 
was reduced by large doses of morphine (15-40 mg/kg). In 
the one experiment outlined in Methods in which recurrent 
inhibition was studied on the right side with the L6 dorsal 
root cut, and on the left with this root intact, the initial 
dose of morphine (10 mg/kg given slowly over 5 minutes) re­
duced recurrent inhibition on the left to a greater extent 
(30% reduced to 10%) than that on the right (30% reduced to 
20%). With this dose the direct inhibition increased from 
38% to 50%. Hence if the observed left sided recurrent in­
hibition included direct inhibition effects from afferents 
entering the spinal cord in the intact L6 dorsal root, these 
were minimal, as they would have made the left sided inhibi­
tion relatively resistant to morphine when compared with the 
right, whereas the opposite effect was observed. Subse­
quent doses of morphine, to a total of 50 mg/kg, reduced the 
direct inhibition to 20%, and both recurrent inhibitions
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to 6-10%.
In some experiments in which morphine did not completely 
suppress recurrent inhibition, dihydro-3-erythroidine hydro­
bromide (1-2 mg/kg) was given intravenously, and this further 
reduced the amplitude and duration of recurrent inhibition 
without having any effect on direct inhibition.
In three experiments, increasing doses of strychnine 
hydrochloride were given intravenously (total 0.25 mg/kg) , 
and in each animal progressive and parallel reductions occurred 
in both recurrent and direct inhibition.
(iii) Morphine and the inhibition of Renshaw cells by 
squeezing the hind paw
This inhibition was not significantly reduced by morphine 
administered with currents of 40-60 nA for periods of up to 
20 min. near three different Renshaw cells. With these re­
latively large doses of morphine, cell firing became irregu­
lar with high frequency bursts interspersed with silent 
periods.
(iv) Electrophoretically administered morphine and the syna­
ptic activation of Renshaw cells.
(a) Ventral root stimulus
In the early series of experiments ventral roots 
were stimulated maximally and the following effects were 
ob s e rve d .
(1) With the exception of the first, the latencies of
individual action potentials were prolonged: the effect
gradually increasing with succeeding action potentials. 
Figure 11 A illustrates this effect. The arrow marks 
the position of the fourth action potential in all three 
records, and the latency shift of 1.9 msec was a typical 
finding in seventeen of nineteen cells studied in this 
fashion. Morphine ejected with currents of 40 nA had 
no effect on the other two neurones.
(2) The number of action potentials in response to a
A
CONTROL
MORPHINE 40 nA 2 MIN
MORPHINE OFF 4 min
Fig. 11
The firing of a Renshaw cell in response to a 
stimulus to a ventral root (VR) and dorsal root (DR).
A. Firing in response to a maximal ventral root stimulus 
before, during and after the electrophoretic administration 
of morphine ( U O nA). The arrows mark the position of the 
fourth action potential in each record. Abscissa t msec.
B. Upper row - control observations in response to a 
maximal ventral root stimulus and a dorsal root stimulus. 
Middle row - firing patterns produced by the electropho­
retic administration of morphine (20 nA) for 2 mins.
Lower row - Z4 minutes after the cessation of the ejection 
of morphine. The arrows mark the position of the fourth 
action potential in each record. Abscissa: msec.
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single ventral root stimulus increased. For example, 
one cell, showed an increase from a mean value of 16 to 
one of 20 after the administration of morphine (40nA) 
for two minutes.
(3) The shape of individual action potentials changed, 
the spikes becoming broader.
As an increase in the number of action potentials 
in response to a ventral root volley may have resulted from 
an increase in the excitability of the postsynaptic membrane, 
a study was made of the effects of the excitants acetylcholine 
and DL-homocysteate, and of the depressants, glycine and 
Y-aminobutyrate on the responses of Renshaw cells to maximal 
ventral root stimuli. The effects of these compounds were:
(1) Acetylcholine. With two of three cells, concen­
trations of acetylcholine which produced a slight in­
crease in the number of action potentials, increased 
the latencies of the second to the sixth action poten­
tials, (those beyond the sixth were not measured).
The latency of firing of the other cell was not affected.
(2) DL-Homocysteate. This excitant also increased 
the latencies of the early action potentials with con­
centrations that increased the number of spikes evoked 
by a maximal ventral root volley. The effect was seen 
in three of four cells.
(3) Glycine. In three of four cells, doses of glycine
which produced a 25-50% reduction in the number of 
action potentials had no effect on the latency of cell 
firing (again measuring only the first six action poten­
tials) . In the fourth cell, a 50% reduction in the
number of action potentials was accompanied by a reduc­
tion of the latency of cell firing.
(4) y-aminobutyric acid. In the two cells studied, 
both a reduction in the total number of action poten­
tials and an increase in the latency of firing were ob­
served .
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The increase in latencies produced by the excitants 
ACh and DLH, is probably related to the intense initial 
depolarisation of a Renshaw cell produced by a maximal ven­
tral root stimulus which presumably releases acetylcholine 
virtually simultaneously at all of the axon collateral syn­
apses on the neurone (Eccles, e t al . , 1954a; Eccles, Eccles ,
Iggo and Lundberg, 1961; Curtis and Ryall, 1966b). The 
initial action potentials are commonly subnormal in height, 
show no significant change in frequency after the admini­
stration of an anticholinesterase and are relatively resis­
tant to intravenous DHßE (Eccles et al., 1954a). An
increase in the latencies of these initial action potentials 
following intravenous eserine sulphate (0.2 mg/kg) is pre­
sent in figure 13 of Eccles et al. (1954a): there is a
doubling of the number of action potentials in response to 
a maximal ventral root stimulus following physostigmine , 
and the latency shifts in spikes 2 to 6 are comparable to 
those produced in this present study by an amount of acetyl­
choline which doubled the ventral root response. As the 
first action potential occurs on the rising phase of the 
excitatory postsynaptic potential (Eccles et a l . 1954a) and
hence before the period of intense depolarisation, its lat­
ency is unlikely to be changed by substances which produce 
depolarisation. Although frequently obscured by the field 
potential produced by antidromic firing of motoneurones , 
when measured, the latency of the first action potential 
produced by a maximal ventral root stimulus was not shortened 
by any substance administered electrophoretica1ly. In
view of these findings experiments were performed using sub- 
maximal stimuli to the ventral roots.
There was considerable variation in the latency of the 
last of two to four action potentials which followed a sub- 
maximal ventral root stimulus. For instance, a cell might
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fire three times to one stimulus, then four times to the 
next, and the latency of the third action potential in the 
first response would equal that of the fourth in the second, 
the latency of the first two spikes being identical in both 
responses. Under these circumstances, the arithmetic mean 
latency of the third action potential in the absence of 
variance is misleading, and control calculations were per­
formed only on records having four or more action potentials. 
With the incresed number of responses during the ejection 
of an excitant, this problem did not arise.
The following results were obtained using submaximal 
stimuli.
(a) In all seven cells tested, morphine (ejecting current 
of 20 to 30 nA for periods of from 1 to 3 minutes) increased 
the number of action potentials per stimulus, and increased 
the latencies of the first three.
(b) Of seven cells tested with acetylcholine, the latencies 
of the first three action potentials of three cells were 
reduced, those of two cells were increased and those of the 
other two cells were unaltered. In all cases the number
of action potentials in response to a stimulus increased by 
approximately 25 to 100%.
(c) The latencies of the first three action potentials of 
both cells tested with DLH was shortened, and the number of 
spikes increased by approximately 25-50%.
Figure 12 illustrates results obtained in an experiment 
in which post stimulus interval histograms were constructed 
using a computer. Morphine (30 nA for 2 minutes) slightly 
increased the time at which the cell was most likely to fire 
first, and there was a greater increase in the time at which 
it was most likely to fire again. The increase in the num­
ber of action potentials produced by this concentration of 
morphine was similar to that resulting from the uncontrolled 
diffusion of acetylcholine (0 nA) from the micropipette.
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The effects of electrophoretically administered 
morphine and acetylcholine on the firing of a Renshaw cell 
in response to a submaximal ventral root stimulus. A 
computer analysed the action potentials in each response in 
6l4 time intervals each of 125usec* Two hundred responses were 
summed in this way to prepare a post stimulus histogram of 
the probability of firing at any instant. The ventral
root was stimulated at two second intervals.
VR STIM DR sum
CONTROLS i1 % ^
Fig. 13
The firing of a Renshaw cell in response to a 
stimulus to a ventral root (VR) and dorsal root (DR). 
Upper row, control responses. Middle row, responses 
produced by the electrophoretic administration of 
morphine 2|0 nA (2 mins.). Lower row - 3 min. after the
cessation of the ejection of morphine
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Figure 12 indicates that this concentration of acetylcholine 
shortened the time at which the cell was most likely to fire 
a second time, but had no effect on the timing of the first 
action potential.
(b ) Dorsal root stimulus
The pattern of firing of Renshaw cells to a dorsal root 
stimulus varies greatly (Curtis and Ryall, 1966b). Most 
commonly 3 or 4 action potentials were followed by a pause 
of 4 to 5 msec, and then a variable number of action poten­
tials. In these cases the latencies of only the initial 
3 or 4 action potentials were measured, as the pause may re­
present a period of inhibition. In one case, the response 
consisted of an uninterrupted series of action potentials, 
and the latencies of all of these were measured.
With currents and times of administration of morphine 
similar to those affecting the ventral roots responses, the 
following results were observed.
(1) Action potential latencies were not prolonged.
In 2 of 4 cells they were unchanged, and in the remain­
ing two cells latencies were shortened.
(2) The number of action potentials per stimulus in­
creased. This was usually of the order of 100%.
(3) Individual action potentials became broader.
Figure 11 compares the effect of morphine on the firing
of one Renshaw cell by volleys evoked by dorsal and maximal 
ventral root stimulation. The arrow marks the position of 
the fourth action potential in each record. The latencies 
of dorsal root responses were inconstant, and the records 
illustrated represent the mean of several responses.
Figure 13 shows records from another cell with a slower 
oscilloscope sweep speed and illustrates the increase in the 
total number of action potentials under the influence of 
morphine.
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In one case dihydro-3-erythroidine was administered 
electrophoretica1ly to a Renshaw cell which could be fired 
by both dorsal and ventral root stimuli. Action potentials 
following the ventral root stimulus were almost completely 
abolished, whilst there was a slight increase in the number 
in response to a dorsal root stimulus. Hence the dorsal 
root stimulus did not activate this Renshaw cell by a chol­
inergic mechanism, as would be expected if the firing re­
sulted from the discharge of motoneurones.
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DISCUSSION
The results obtained in this analysis of spinal inhi­
bition, namely a parallel reduction in the direct and re­
current inhibition of motoneurones with high doses of mor­
phine, are compatible with glycine, or a glycine-like amino 
acid, being the inhibitory transmitter at both types of in­
hibitory synapse upon motoneurones. The electrophoretic 
data indicate that morphine is a weak antagonist of glycine 
when compared with strychnine, and hence relatively large 
systemic doses are likely to be necessary to affect spinal 
inhibitions.
It seems probable that the apparent lack of sensitivity to 
morphine of direct inhibition, when compared with that of re­
current inhibition, observed by other workers (Kruglov, 1964; 
Felpel, Sinclair and Yim, 1968, 1970) stems from two factors:-
(i) Failure to use sufficient morphine to affect direct 
inhibition and
(ii) The susceptibility of recurrent inhibiton to the circu­
latory effects of morphine.
The increased effectiveness of direct inhibition with 
low doses of morphine cannot be satisfactorily explained, 
but may stem from an action of morphine on inhibition along 
pathways of local and descending origin converging upon the 
interneurone of the direct inhibitory pathway. An increase 
in the excitability of this interneurone through this mech­
anism could outweigh an effect of morphine at inhibitory syn­
apses on motoneurones, particularly as large numbers of the 
latter were simultaneously activated by the stimulus to a 
peripheral nerve.
This mechanism could account for the enhancement of 
direct inhibition by low doses of morphine observed by Kruglov 
(1964) and in this study. A similar explanation has been 
suggested for the varying effects of intravenous strychnine
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(0.1 mg/kg) on the inhibition of Renshaw cells by supraspinal 
stimulation and by squeezing the hind paw (Curtis, 1968) .
The failure of electrophoretica1ly administered morphine 
to influence the inhibition of Renshaw cells by squeezing 
the hind paw was probably due to a failure to attain a high 
enough concentration of morphine over a sufficiently large 
area of the cell. Again, this probably relates to the re­
lative weakness of morphine as an antagonist of glycine. 
Difficulty is experienced in fully suppressing this inhibi­
tion with electrophoretically administered strychnine (Biscoe 
and Curtis, 1966) , a thirty times more potent antagonist of 
glycine than morphine.
Morphine and excitation of Renshaw cells
Although dihydro-ß-erythroidine was administered to 
only one cell, it will be assumed that in general the firing 
of Renshaw cells in response to a stimulus to the dorsal 
root is mediated by a non-cholinergic synapse (see Curtis 
and Ryall, 1966) . The different behaviour of this firing 
to morphine, when compared with that produced by ventral 
root stimulation, also makes this likely.
When morphine was administered electrophoretica1l y , the 
response to both dorsal and ventral root impulses was enhan­
ced and individual action potentials were broadened. This 
was usually accompanied by a change in the spontaneous firing 
pattern to one of irregularly placed bursts of 10-20 spikes 
with a mean frequency within each burst of the order of 
500/sec. These phenomena are also seen with strychnine 
administered electrophoretically (Curtis, 1967) and probably 
represent a depolarisation of the postsynaptic membrane and 
an interference with spike generation. The increase in 
latency observed in the firing produced by submaximal vental 
root stimulation never occurred when the dorsal roots were 
stimulated, and hence either morphine modified the post­
synaptic action of released acetylcholine or interfered with
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its release. Morphine did not antagonize the excitant 
effect of electrophoretica1ly administered acetylcholine on 
Renshaw cells, and prolonged administration of morphine re­
sulted in bursts of firing regardless of whether the cell 
was firing spontaneously or in response to DLH or ACh.
Hence it is likely that morphine impaired the output of acetyl­
choline from motoneurone axon collaterals rather than blocked 
the postsynaptic action of this transmitter. The speed of 
onset and recovery with which this occurred makes it unlikely 
that this was due to a lowered synthesis of acetylcholine, 
although such an action has been reported in cerebral corti­
cal slices (Howes, Harris and Dewey, 1970). Hemiehe1iniurn-3,
known to inhibit the uptake of choline at the neuromuscular 
junction and autonomic ganglia and thereby to interfere in­
directly with ACh synthesis (Scheuler, 1960) increases the 
latency of the first action potential evoked by a submaximal 
ventral root stimulus after some 10-20 minutes of repetitive 
stimulation when administered electrophoretically near Ren­
shaw cells, (Quastel and Curtis, 1965). Thus presumably 
the presynaptic shore of ACh in axon collateral terminals 
is relatively large, and the rapid effect of morphine re­
sulted from interference with release rather than with syn­
thesis .
An interference by morphine with the release of acetyl­
choline from nerve terminals has been concluded from studies 
on intestine (Paton, 1957) , autonomic ganglia (Kosterlitz,
Lees and Watt, 1969) and heart (Kennedy and West, 1967) . 
Because of the difficulties involved in drawing comparisons 
between concentrations attained in microelectrophoretic ex­
periments and those attained after intravenous administra­
tion of a compound, it is not possible to relate these 
effects on evoked action potential latencies to the suscepti­
bility of recurrent inhibition to intravenous morphine nor 
to the action of morphine as an analgesic. Convulsions
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from morphine are associated with large doses (Tatum, Seevers 
and Collins, 1929) , and hence it is unlikely that antagonism 
of glycine action is at the basis of morphine analgesia.
The amounts of morphine administered e 1 e c t r ophor e t i c a 1 ly to 
obtain effects on Renshaw cell spike latencies were greater 
than those required to block the action of glycine, but this 
does not exclude this action as being relevant to morphine 
analgesia. To influence synaptic events with a substance 
administered microelectrophoretically, requires higher con­
centrations in the vicinity of the electrode tip than those 
necessary to affect the action of a substance also admini­
stered microelectrophoretically, as the interfering substance 
has to attain an adequate concentration at peripheral syn­
apses. Hence the doses of morphine used electrophoreti- 
cally to block the action of glycine and those used to inter­
fere with the activation of Renshaw cells cannot be compared.
The paradoxical results obtained when excitants were 
administered to Renshaw cells already excessively depolarized 
by a maximal ventral root stimulus illustrate the dangers 
of investigating cells subjected to grossly abnormal inputs. 
On the basis of the failure of DH3e to affect the latency of 
the first action potential in response to a maximal ventral 
root stimulus, Weight (1968) denied the existence of Renshaw 
cells, claiming that this first action potential was an 
impulse propagating into the axon collateral terminal and 
subsequent spikes were generated by nicotinic excitation of 
the terminal by synaptically released acetylcholine. When 
a submaximal stimulus is used however, the first action 
potential is readily abolished by electrophoretically ad­
ministered DHßE (Curtis and Duggan, 1969). Furthermore the 
first action potential is suppressed by hemicholinium-3 
(Quastel and Curtis, 1965), in the absence of a reduction in 
the sensitivity of Renshaw cells to A C h , and is thus a syn­
aptic response and not an electrically propagated impulse 
in a fibre.
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V. THE POTENTIATION OF AMINO ACID EXCITATION AND 
DEPRESSION BY ORGANIC MERCURIALS AND TH10SEMICARBÄZI PE
One of the criteria that a substance needs to satisfy 
to be regarded as a synaptic transmitter is identity of re­
sults from pharmacological tests of the substance and of the 
appropriate synaptic event. Interference with the inacta- 
vation of a substance administered near neurones is one such 
procedure which could be expected to enhance and prolong its 
effects and would provide support for its role as a trans­
mitter if, in addition, the appropriate synaptic event was 
similarly accentuated. Released transmitters could be re­
moved from the syaptic environment by a number of processes 
including diffusion, extracellular enzymic modification, 
binding to extraneuronal sites and uptake into surrounding 
cells. When an anticholinesterase is administered near 
Renshaw cells, the response of these cells to both ventral 
root stimulation and the administration of acetylcholine is 
potentiated, thus providing evidence that acetylcholine is 
the transmitter at this site (Curtis and Eccles, 1958;
Curtis, Phillis and Watkins, 1960). Attempts to interfere 
with the inactivation of electrophoretically administered 
amino acids have been largely unsuccessful. Curtis, Phillis 
and Watkins (1960) , detected no change in the action of the 
excitant amino acids, L-glutamate, L-aspartate and L-cysteate 
by the electrophoretic administration of p-chloromercuri - 
benzoate, isoniazid, iproniazid, thiosemicarbazide, benzoate, 
quinine, ephedrine , p-phenylenediamine, fluoride, cyanide 
and methionine sulphoximine.
Contrary to these findings, intravenously administered 
theosemicarbazide has been reported to enhance and prolong 
the excitant action of L-glutamate on a variety of supra­
spinal neurones in the rat (Steiner and Ruf, 1966a,b) and 
to prolong the depressant action of GABA on hippocampal
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neurones of the same animal (Steiner and Ruf, 1967) . The 
reversal of these effects by prior administration of pyrid- 
oxal-5-phosphate has led to the proposal that inactivation 
of electrophoretically administered L-glutamate and GABA is 
predominantly an enzymic process (Steiner and Ruf, 1966a,b, 
1967), and presumably located extracellularly.
Curtis, Hosli and Johnston (1968b) , found that the 
depressant action of glycine on spinal neurones was enhanced 
and prolonged by electrophoretically administered p-mercuri- 
benzoate (pMB). Although the effect appeared to be rela­
tively specific for glycine, an increased effectiveness of 
GABA by pMB was not excluded because of the technical diffi­
culties experienced in these experiments. Currents of pMB 
greater than 20 nA could seldom be passed without gross elec­
trical noise or marked depression of cell firing. The use 
of a more water soluble mercurial, p-mercuriphenylsulphonate, 
pMS , has minimized these technical difficulties and a study 
has been carried out on the effect of this mercurial on amino 
acid excitation and depression of spinal neurones.
In view of the possibility that glycine, or a "glycine­
like" amino acid, is the transmitter at strychnine sensitive 
inhibitory synapses upon Renshaw cells (see Curtis e t al. 
1968a), attempts were also made to enhance with pMS the sub- 
maximal inhibition of these cells evoked by volleys in affer­
ent nerve fibres resulting from squeezing the ipsilateral 
hind paw (Wilson and Talbot, 1963; Wilson, Talbot and Kato, 
1964) .
The findings of Steiner and Ruf (1966a,b, 1967) were 
reinvestigated by studying the action of intravenously ad­
ministered thiosemicarbazide on the action of L-glutamate 
and GABA on spinal neuones. Hydrazinopropionic, a potent 
inhibitor of central GABA transaminase and L-glutamate 
decarboxylase (van Gelder, 1968, 1969) was also tested elec­
trophoretically for possible effects on the action of simi­
larly administered L-glutamate and GABA on spinal neurones.
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RESULTS
(i) p-Mercuriphenylsulphonate and amino acid excitation and 
depression of spinal neurones by amino acids.
Although the difficulties previously encountered 
with pMB were experienced to a lesser extent with pMS , suffi­
cient observations were made in 14 animals to show that when 
administered electrophoretically, this mercurial had profound 
concentration dependent effects on the action of a number of 
amino acids. These effects fell into three groups.
(a) When ejected with relatively low anionic currents (l-5nA) 
pMS enhanced the inhibitory effect of glycine, usually 
with little or no increase in the depressant action of 
other amino acids.
(b) Increasingly the ejecting current by a factor of 5-10, 
almost invariably resulted in an increase in the effect­
iveness of these other depressant amino acids (GABA, 
3-alanine, L and D-a-alanine), in the absence of any 
increase in the sensitivity of neurones to excitant 
amino acids. These effects of pMS had a latency of
1-2 min from the beginning of the electrophoretic 
ejection, and were usually reversible, recovery occurr­
ing within 2-10 mins when pMS was administered with 
currents less than 20-25 nA.
(c) Further increasing the current of pMS (30-60nA) enhanced 
the excitant action of L-glutamate and L-aspartate with 
a lesser effect on that of D-glutamate and DLH, there 
being minimal or no change in the effectiveness of ace­
tylcholine as an excitant of Renshaw cells. Five to 
ten minutes were required for these effects to appear 
and partial recovery was observed in only one cell; 
this commenced one hour after cessation of the ejection 
of p M S .
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Fig. 1^
Effect of p-mercuriphenylsulphonate on the 
depressant action of glycine and GABA. The rate of spon­
taneous firing of a dorsal horn interneurone was depressed 
by electrophoretically ejected glycine (2 n A ) and GABA 
(20 n A ), indicated by the solid and broken horizontal lines, 
respectively: A, control; B, during the administration
of pMS with a current of 10 nA; C, during and after the 
ejection of pMS with a current of 25 nA (see text). The 
current was terminated at the time indicated by the vertical 
broken line. Ordinates: spikes per second. Abscissae:
time in minutes.
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The effects of pMS on the reduction in the spontaneous 
firing rate of a dorsal horn interneurone by amino acids are 
illustrated in Fig. 14. During the control period (Fig.14) , 
glycine, ejected with a current of 2nA reduced the firing 
by approximately 30% whereas GABA (20nA) resulted in a re­
duction of approximately 50%. The electrophoretic ejection 
of pMS with a current of 5 nA (10 mM solution, 165 mM NaCl, 
pH 8) for 3 1/2 minutes produced a slight increase in the 
glycine effect which was, however, more apparent when the 
pMS current was increased to 10 nA (Fig. 14 B ) . After 
three minutes both glycine and GABA depressed the firing of 
this neurone by 50%, the electrophoretic currents being 
identical to those used in the control observations of Fig.
14 A. A further increase of the current ejecting pMS to
15 nA (5 1/2 minutes) and eventually to 25 nA (3 minutes) 
further enhanced the action of both glycine and GABA (Fig.
14 C) : both amino acids depressed the firing of the neurone
by approximately 70%. Following the termination of the 
ejection of the mercurial (Fig. 14 C ) , progressive recovery 
of the amino acid effects occurred within 4-5 minutes. The 
enhancement of both depressant amino acids could have re­
sulted from a decrease in the distance between the cell and 
the electrode tip. This can be excluded however, by an 
absence of any change in sensitivity to the continually 
ejected DLH and by the consistant occurrence of recovery. 
Forty minutes after this series, the effects of L-a- and 
D-a-alanine, contained within other barrels of the seven 
barrel micropipette, were also determined upon this inter­
neurone. In the control period (Fig. 15 A ) , D-a-alanine 
(30nA) depressed the firing rate by approximately 20%, and 
L-a-alanine (25 mA) by 12%. The continuous ejection of 
pMS with currents of 15 nA (3 minutes) and 25 nA (4 minutes) 
produced little or no enhancement of the action of either
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Fig. 15
Effect of p-,mercuriphenylsulphonate on the 
depressant actions of a-alanine. The rate of spontaneous 
firing of a dorsal horn interneurone was depressed by 
electrophoretically ejected L-a-alanine (25 n A ) and 
D— o-alanine (30 n A ), indicated by the solid and broken 
horizontal lines, respectively: A, control; B, during
the administration of pMS with a current of 35 nA (see 
text); C, continuous with B. The pMS current was 
terminated at the time indicated by the vertical broken 
line. Ordinates: spikes per second. Abscissae:
time in minutes
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amino acid. However after a period of 9 minutes adminis­
tration of pMS with 35 n A , both optical isomers of a-alanine 
produced approximately 50% depression (Fig. 15 B) and par­
tial recovery occurred within 4-5 minutes of terminating the 
pMS-ejecting current (Fig. 15 C ) .
Experiments of this type were carried out on a number 
of interneurones and Renshaw cells with the following amino 
acids: glycine (18 neurones) , GABA (13) , 3-alanine (3) ,
D-a-alanine (5), L-a-alanine (5). In each case the effect 
of glycine was increased to a greater degree than that of 
other amino acids and by lower currents (concentrations) of 
pMS .
In a number of experiments, the excitant action of 
glutamate, aspartate, DL-homocysteate and acetylcholine, and 
the "spontaneous" activity of neurones, were apparently pro­
gressively depressed by p M S , an effect attributed to two 
factors. Firstly, the amount of depression could often be 
reduced by increasing the current used to retain glycine, 
GABA and other depressants within the various barrels of the 
micropipette, beyond that required to give the usual retain­
ing voltage of 0.5 V: hence it was assumed that pMS had in­
creased the effect of the small amounts of amino acids which 
were leaking from these barrels. Secondly, decreased eff­
ectiveness of excitants was sometimes associated with an in­
crease in the electrical resistance of recording and amino- 
acid containing barrels, and presumably modification of 
tissue proteins in the vicinity of the micropipette tip by 
the organic mercurial limited the access of the excitants 
to neurone receptors. When none of the barrels of a multi­
barrel micropipette contained depressant amino acids, clear 
evidence was obtained for potentiation by pMS (30-60 nA) of 
the excitant action of glutamate, aspartate and DL-homocys- 
teate upon spinal neurones, with no or minimal change in 
the effectiveness of acetylcholine as an excitant of Renshaw 
cells .
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Fig. 16
Effect of p—mercuriphenylsulphonate on the 
excitation of a Renshaw cell. The cell was excited by 
the electrophoretic administration of acetylcholine 
(ACh, 0 nA ) , L-glutamate (L~glut , J^O nA ) , L—aspartate 
(L-Aspart, JL|0 nA), D-glutamate (D-glut, 60 nA) and 
DL~homocysteate (DLH, 10 nA). A, Control; B, immediately 
after the administration of pMS for 10 min (see text).
The vertical arrows indicate frequencies of the order of 
150 spikes per second. Ordinates: spikes per second.
Abscissae: time in minutes.
The action of pMS on the excitation of a Renshaw cell 
by amino acids and acetylcholine is illustrated in Fig. 16, 
and these results are similar to observations made on three 
other Renshaw cells and 8 interneurones, although these 
latter cells, of course, are not affected by ACh. The 
control responses of Fig. 16 A resulted from the electro­
phoretic administration of acetylcholine (0 n A ) , L-aspartate 
(40 nA) , L-glutamate (60 nA) and DL-homocysteate (10 nA).
An anionic current of 30 nA ejected pMS for 5 1/2 minutes; 
this was increased to 40 nA for a further 4 1/2 minutes and 
within one minute of this increase there was progressive 
enhancement of the sensitivity of the neurone to the amino 
acids. The responses of Fig. 16 B were recorded immediately 
after the pMS-e]ecting current was terminated, at which time 
the background "spontaneous" firing of the cell was increased 
with an irregular burst-type of firing and, although the 
sensitivity to acetylcholine was increased slightly, that to 
the amino acids, particularly aspartate and glutamate, was 
increased to a much greater extent. As suggested by this 
figure and confirmed with other cells, the excitant effects 
of DL-homocysteate and D-glutamate were frequently increased 
less than those of L-aspartate and L-glutamate, although 
technical difficulties in these experiments prevented a de­
tailed examination of the differential sensitivity of exci­
tant amino acids to p M S . In one experiment on an inter­
neurone, the ejection of pMS with a current of 60 nA clearly 
enhanced the excitant action of both D- and L-aspartate 
without affecting that of N-methy1-D-aspartäte, a powerful 
neuronal excitant (Curtis and Watkins, 1963).
(ii) p-Mercuriphenylsulphonate and the inhibition of 
Renshaw cells.
Using currents of pMS of up to 60 n A , no change in 
the inhibition of Renshaw cells (7 cells in 3 animals) 
produced by squeezing the ipsilateral hind paw was observed,
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despite enhancement of the effect of glycine on the same 
cell. With such high doses of pMS irregular bursts of 
firing were common.
(iii) Thiosemicarbazide.
Five experiments were performed in which observations 
were made of the sensitivity of spinal neurones (four 
Renshaw cells, one dorsal horn interneurone) to L-glutamate, 
D-glutamate, 3~alanine, GABA, glycine and acetylcholine 
(Renshaw cells only) before, and at frequent intervals for 
as long as 120 minutes after, the intravenous administration 
of thiosemicarbazide (100 mg/kg). Although as described 
in Methods there were considerable difficulties in maintain­
ing constant recording conditions over this period, thio­
semicarbazide produced no significant enhancement or pro­
longation of the action of any of these excitants and de­
pressants .
Hydrazinopropionic acid
Electrophoretica1ly administered hydrazinopropionic 
acid was a weak depressant of spinal neurones by comparison 
with GABA, and did not enhance the effect of simultaneously 
administered GABA or glycine. This depression was not re­
duced by doses of strychnine sufficient to block the action 




Organic mercurials, through binding to sulphydryl 
groups, affect a wide variety of enzymes and transport pro­
cesses (reviewed by Webb, 1966) . Through these actions 
mercury can have generalised metabolic effects on cells.
The data for the susceptibility to mercury of the various 
functions of neurones are meagre, but Giacobini (1966) found 
that impulse activity in the isolated crustacean stretch 
receptor was more susceptible to interference by mercury than 
was oxygen uptake. When administered electrophoretically 
in these experiments, concentrations of pMS which reversibly 
affected the action of depressant amino acids had no detect­
able effect on cell excitability, although the increased and 
irregular "spontaneous" activity of neurones produced by 
higher concentrations of pMS may indicate more generalised 
metabolic effects.
Mercurials inhibit many transport processes, for 
instance transport of inorganic ions by a variety of animal 
and plant cells, transport of glucose, urate and amino 
acids by intestine, transport of inorganic ions, urate and 
amino acids by kidney tubule cells, and secretion of H by 
gastric mucosa (Webb, 1966). Transport of amino acids into 
brain slices is considerably less substräte-specific than 
are the known CNS enzymes for metabolism of amino acids.
Amino acids have been grouped into six transport classes
on the basis of the interference with the uptake of
one substance by another: small neutral (including glycine,
3-alanine, L and D-a-alanine), large neutral, small
basic, large basic, acidic (including L and D-aspartate),
and GABA-like (Blasberg and Lajtha, 1966) .
p-Mercuribenzoate inhibits the transport into rat
brain slices of glycine, GABA, DL-aspartate and L-lysine,
representatives of four different transport classes, there
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being no significant differences between these amino acids 
on the basis of percentage inhibition of uptake by the mer­
curial (Curtis, Duggan and Johnston, 1970) .
The several enzymes likely to be involved in the meta­
bolism of the different depressant amino acids tested electro- 
phoretically show a wide variation in susceptibility to in­
hibition by mercurials in vitro (Baxter and Roberts, 1958; 
Roberts and Simonsen, 1963; de March! and Johnston, 1969; 
Johnston and Vitali, 1969a,b) . Although observed results 
may indicate that pMS has differential effects upon a number 
of extrace 1lularly located enzymes in vivo, or even alters 
the sensitivity of receptors to amino acids, the potentiation 
of D-a-, L-a-alanine and 6-alanine to the same extent, sug­
gests that the increased effectiveness of depressant amino 
acids in the presence of pMS does not arise from an inhi­
bition of enzymes metabolizing amino acids in the synaptic 
environment. In the case of GABA, this conclusion is 
supported by the lack of effect of e1ectrophoretically ad­
ministered hydrazinopropionic acid and intravenously admini­
stered thiosemicarbazide on depression of spinal neurones 
by GABA. Relatively high GABA transaminase activity has 
been described in feline spinal grey matter (Graham and 
Aprison, 1969) , and hydrazinopropionic acid is an inhibitor 
of this enzyme (van Gelder, 1968) comparable in potency to 
the cholinesterase inhibitors which potentiate the firing 
of Renshaw cells by acetylcholine.
The enhancement of the action of a variety of acidic 
a m m o  acids by pMS , the lack of effect of thiosemicarbazides 
and the similarities in time course of action of the optical 
isomers of glutamate and aspartate as neuronal excitants 
(Curtis e t a1 . , I960; Crawford and Curtis, 1964), suggest
that extracellular enzymic inactivation is not an important 
means of removing these amino acids from the vicinity of 
neurones. Excitation of Renshaw cells by acetylcholine was
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relatively insensitive to the action of p M S . The concentra­
tion of the mercurial attained near Renshaw cells was appar­
ently lower than that required to block acetylcholine recep­
tors (Karlin and Bartels, 1966; Zupancic, 1969) or to inhibit 
cholinesterase. Cholinesterases of human blood are relative­
ly insensitive to p-mercuribenzoate (Mounter and Whittaker, 
1953) .
To draw parallels between the grouping of amino acids 
observed in brain slice uptake experiments and the groupings 
observed in potentiation by pMS in mi eroe1ectrophoretic 
experiments, implies that the transport systems presumed to 
remove microelectrophoretica1ly administered amino acids 
differ in their susceptibility to interference by the mercu­
rial, a difference not observed in brain slice experiments 
(Curtis et a1 . , 1970) . Either the systems studied in brain
slice experiments differ from those operating in vivo which 
seems highly likely in view of the metabolic requirements 
of brain tissue, or the discrepancy lies in the different 
methods of administration of compounds, one uniformly in 
the bathing medium and the other from a point source.
When administered electrophoretically, the mercurial 
is unlikely to diffuse through the extracellular space as 
freely and extensively as the amino acids, being restricted 
by interaction with tissue sulphydryl groups and the possible 
formation of insoluble complexes (Curtis, Perrin and Watkins, 
1960; Jaeger, 1965) . Glycine was the most potent amino 
acid depressant used, and the low amounts administered pro­
bably affected a smaller area of cell membrane than did the 
weaker compounds administered with higher currents. Total 
suppression of inactivating systems in the vicinity of the 
tip of the electrode with low amounts of pMS would thus 
have more effect on the action of glycine than on that of 
a less potent compound. If receptors for excitant amino
acids were located further from the neurone soma (the pre­
sumed location of the recording microelectrode and the ma­
jority of receptors for inhibitory amino acids) , higher 
currents and longer periods of time would be required to 
attain similar local concentrations of the mercurial at the 
more distant sites. Microelectrophoretic methods may thus 
not be suitable for comparing the relative susceptibilities 
of amino acid inactivating processes to p M S .
These considerations suggest that transport into cellu­
lar elements may well be a mechanism of inactivation of 
depressant and excitant amino acids in the vicinity of feline 
spinal interneurones. A similar mechanism has been sugges­
ted for the removal of synaptically released GABA in Crust­
acea (Iversen and Kravitz, 1968). As transport to the
intracellular phase much be followed by enzymic processes, 
it is possible that the convulsant action of thiosemicarba- 
zide and related substances in mammals (Williams and Bain, 
1961) is associated with the inhibition of essentially 
intracellular enzymes, with perhaps subsequent disturbances 
of presynaptic stores of transmitter amino acids. The 
literature relating total brain GABA and convulsions follow­
ing systemic administration of hydrazides is confused.
Earlier reports indicated a lack of correlation between the 
onset of seizures and the decrease in concentration of 
cerebral GABA (Balzer, Holtz and Palm, 1960; Baxter and 
Roberts, 1960; Maynert and Kaji, 1962). More recently 
(Abrahams and Wood, 1970) good correlation has been found. 
These studies suffer from an inability to differentiate 
between intra-and extracellular GABA and between different 
compartments of intracellular GABA.
It is possible that the effects observed in the rat 
by Steiner and Ruf (1966a,b) resulted from a generalised 
elevation of excitability of supra spinal neurones by 
thiosemicarbazide rather than a specific enhancement of the
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excitant action of L-glutamate. Their findings of poten­
tiation of GABA by systemic thiosemicarbazide (Steiner and 
Ruf, 1967) are not convincing, one illustration in particu­
lar shows a partial block of the action of GABA upon a 
neurone following thiosemicarbazide.
A major aim of this investigation was to find an agent 
which accentuated in a specific fashion both the inhibitory 
or excitatory action of a particular amino acid and the 
appropriate synaptic process. Although some degree of 
selectivity could be demonstrated, in that the mercurials 
enhanced the action of glycine at lower concentrations than 
those required to affect the action of other amino acids, 
including GABA, the degree of specificity is probably in­
sufficient for determining whether glycine or GABA is in­
volved as the transmitter at spinal inhibitory synapses. 
Furthermore, a uniform pericellullar concentration of a 
mercurial probably cannot be obtained by electrophoretic 
administration. Electrophoretically administered pMS did
not modify the synaptic inhibition of Renshaw cells, a 
process for which glycine has been presumed to be the trans- 
metter because of its susceptibility to antagonism by stry­
chnine (Curtis et a 1 . , 1968a) . The lack of action of pMS 
may indicate that the inhibitory transmitter is not glycine. 
More likely a sufficient number of inhibitory synapses may 
not have been influenced by the mercurial: difficulty is 
also experienced in suppressing this inhibition with stry­
chnine administered electrophoretically, presumably be­
cause of difficulty attaining a high enough concentration 
of the alkaloid at receptors relatively remote from the 
electrode which is effectively a point source. However, 
even if concentrations of pMS could be attained by electro­
phoretic administration at a sufficient number of inhibi­
tory synapses to enhance the action of synaptically released
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glycine, the concentration of the mercurial in the immediate 
vicinity of the micropipette tip would probably be high 
enough to influence the action of this and other depressant 
amino acids. Thus it is unlikely that the specificity of 
pMS towards the action of glycine is sufficiently great to 
permit the use of this agent as a pharmacological tool in 
deciding which of the depressant amino acids may operate as 
spinal transmitters. On the other hand, the ability of 
pMS to block the uptake of glycine and other amino acids 
may be of assistance in demonstrating the release of indi­
vidual amino acids by impulses in particular central 
pathways.
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VI. THE SPECIFICITY OF STRYCHNINE AS A GLYCINE 
ANTATONIST IN THE SPINAL CORD
One of the postulates that a putative synaptic trans­
mitter is required to meet is that modification of its action 
by pharmacological agents should be paralleled by a similar 
modification of the appropriate synaptic events (Curtis,
1961; Werman, 1966). Glycine has long been known to be a 
depressant of spinal neurones (Curtis and Watkins, 1960) .
A study of its regional levels in the spinal cord (Aprison 
and Werman, 1965; Davidoff, Shank, Graham and Aprison, 1967) 
and the demonstration that glycine hyperpolarizes motoneu- 
rones (Werman, Davidoff and Aprison, 1967; Curtis, Hosli and 
Johnston, 1968a), led to the proposal that this amino acid 
is a major spinal inhibitory transmitter. Strychnine is a 
pharmacological agent known to influence a variety of in­
hibitions; direct inhibition of spinal motoneurones by im­
pulses in group IA afferents (Bradley, Easton and Eccles, 
1953), recurrent inhibition of motoneurones by impulses in 
axon collaterals (Eccles, Eccles and Fatt, 1956; Curtis,
1959) , inhibition of motoneurones by afferents from skin 
and muscle (Curtis, 1962) , olivo cochlear peripheral inhi­
bition (Desmedt and Monaco, 1960). However, in just-con- 
vulsant doses strychnine does not affect the following in­
hibitions:- recurrent inhibition in the olfactory bulb 
(Green, Mancia and von Baumgarten, 1962) , inhibition of 
Deiters neurones by cerebellar Purkenje cells (Obata, 1967) , 
inhibition in the ventrobasal thalamus (Anderson, Eccles, 
L^yning and Voorhöeve, 1963) , inhibition of hippocampal
pyramidal cells by basket cells (Anderson et al . 1963 ) ,
inhibition of cerebellar Purkinje cells by basket cells 
(Anderson e t a 1 . 1963; Crawford, Curtis, Voorhoeve and
Wilson, 1963) and inhibition of deep pyramidal cells of 
the cortex by local stimulation of the cerebral cortex
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(Crawford et al. , 1963 ; Krnjevic, Randic and Straughan,
1966), by recurrent volleys in pyramidal tract fibres 
(Crawford et al . , 1963 ; Krnjevic, et a l . , 1966) and by
stimulation of thalamic nuclei (Krnjevic et al ., 1966).
Curtis e t a1 . (1968a,b) confirmed that glycine hyper-
polarized spinal neurones and showed that doses of stry­
chnine administered electrophoretically which reversibly 
blocked the action of glycine had no effect on that of 
Y -aminobutyric acid (GABA). Amino acids tested upon spinal 
neurones were divided into two classes on the basis of 
blockade by strychnine. The "glycine like" amino acids 
which were blocked by strychnine included glycine, L-a-ala- 
nine, 3-alanine, L-serine, D-serine, DL-allo-cystathionine,
DL-8-amino-iso-butyric acid and taurine. The "GABA-like" 
amino acids not blocked by strychnine included GABA, y-amino- 
6-hydroxybutyric acid, 3-aminopropane sulphonic acid, 6 -amino 
valeric acid and e-aminocaproic acid.
This antagonism of the action of glycine by strychnine 
administered electrophoretically has been confirmed in the spinal 
cord (Larson, 1969; Davidoff, Aprison and Werman, 1969) , 
cuneate nucleus (Galindo, 1969), Deiters' nucleus (Bruggen- 
cate and Engberg, 1969; Curtis, Duggan and Felix, 1970) 
medullary reticular formation (Hosli, Tebecis and Filias,
1969), oculomotor nucleus (Obata and Highstein, 1970) and 
cerebral cortex (Curtis et a l ., 1968a; Johnson, Roberts and
Straughan, 1970) .
Davidoff, Aprison and Werman (1969), confirmed that 
electrophoretically administered strychnine blocked the 
action of glycine but found that high doses also reduced 
the action of GABA. On the basis of a failure to observe 
a parallel displacement of the glycine dose response curve 
by electrophoretically administered strychnine, they pro­
posed that strychnine was a non-competitive antagonist of 
both amino acids, and that its selectivity in differentiating
between them was poor. Their findings are consistent with 
the proposal of Araki (1965) , that strychnine restricts the 
ion movements underlying the generation of inhibitory post- 
synaptic potentials and hence would be non selective to­
wards substances which produce these potentials.
Roper, Diamond and Yasargil (1969) studied the conduct­
ance change induced in the postsynaptic membrane of the 
Mauthner cell of the goldfish by the electrophoretic of 
GABA and glycine and its modification by strychnine. They 
found that electrophoretically administered strychnine 
blocked the action of glycine without affecting that of GABA 
but when administered intravenously, in amounts adequate to 
block the inhibition of Mauthner cells by stimulating the 
contralateral VIII N, strychnine had no effect on the con­
ductance change induced by locally administered GABA or 
glycine. Higher amounts of strychnine intravenously did 
reduce the action of glycine.
If it is assumed that strychnine acts postsynaptically 
then the results of Roper et al . (1969) imply that the con­
centration of strychnine which blocks the action of glycine 
in the goldfish is in excess of that which blocks the inhi­
bitory transmitter and is just one more of a series of con­
centration dependent effects of strychnine (reviewed by 
Ajmone-Marsan, 1969) , which are discussed later in this
The sis.
In view of these apparently conflicting observations, 
two series of experiments were performed.
1) The specificity of electrophoretically administered 
strychnine in differentiating between glycine and GABA as 
depressants of the firing of spinal neuones was re-examined.
2) The effect of subconvulsive and just convulsive doses 
of intravenously administered strychnine on the action of 
electrophoretically administered glycine and GABA was 
studied.
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In both cases, dose response curves were compiled, as 
apart from implications as to the mode of action of stry­
chnine, they illustrate the activity of a possible anta­
gonist over a range of doses.
5 9
RESULTS
( i ) The effect of e l e c t r o p h o r e t i c a 1ly admi n i s t e r e d  strychnine 
on the glycine d o s e - r espons e curve
Detailed results were obtained from 5 interneurones 
and 2 Renshaw cells which indicated that relatively low c o n ­
cen trations of e l e c t r o p h o r e t i c a l l y  admi nistered strychnine 
di sp la ce d the glycine d o s e - response curve to the right in a 
par al le l fashion w i t h o u t  reducing the p l a teau level, and 
with little or no change in the slope of the straight line 
po rti on of the curve. Contrary to the observations of 
Da vid off  et al. (1969) increased amounts of glycine could 
"overcome" the de c r e a s e d  maximal depr ession resulting from 
a d mi ni st ration of strychnine.
Results from one interneurone are pl otted in Fig. 17. 
Firing  was mai n t a i n e d  at approximately 60 spikes per second 
by co nti nuously a d m i n i s t e r e d  DLH (-15 n A ) , and the response 
(ordinate) is the p e r c e n t a g e  decrease of this rate produced 
by the a d ministration of glycine for a pe riod of 10-30 s e c ­
onds, when m a ximum inhi bition was achieved for that p a r t i c u ­
lar ejecting current. Glycine was retained wi thin the m i ­
cropipette by a current of -9 nA ( a n i o n i c ) . As the rate 
of firing was not e n h anced by increasing this current, and 
reduc tio n to -4 nA resulted  in a pproximately 20% inhibition 
pri or to the a d m i n i s t r a t i o n  of strychnine, zero "dose" was 
taken as -9 nA (anionic) and ejecting currents (dose, a b s ­
cissa) were m e a sured relative to this value. Thus an 
actual cationic e j e c t i n g  current of +10 nA is indicated as 
a "dose" of 19 nA. Three curves are p l otted in Fig. 17 A 
from ob servations made before (filled c i r c l e s ) , and during 
the el ec tr o p h o r e t i c  a d m i n i s t r a t i o n  of strychnine (2 mM in 
165 mM NaCl, r e t a ining current -12 nA) using currents of 
+5 nA (filled triangles) and +10 nA (filled s q u a r e s ) . In 
each case strychnine was ejected for at least 6 minutes in
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Fig. 17
The effect of electrophoretically administered 
strychnine on the dose-response curves of glycine and GABA. 
Ordinate: Percentage inhibition of the firing of a
spinal interneurone (60 spikes/sec in response to 
continuously administered DLH).
Abscissa: Current of the depressant amino acid admini­
stered electrophoretically (nA, log scale).
A. Glycine. Circles, control observations; triangles, 
during the electrophoretic ejection of strychnine, + 5 n-A 
from a 2 mM in 165 mM NaCl solut.; squares, during the 
ejection of strychnine +10 n A .





The effect of electrophoretically administered 
strychnine on the depression of a spinal interneurone by 
glycine and GABA.
The ejecting currents (nA) of glycine and GABA 
are indicated by the numbers overlying solid and broken 
horizontal lines respectively.
A. Control observations, the continually applied retaining 
current of strychnine was -15 n A .
B. During the electrophoretic ejection of strychnine (+1 nA).
C. During the ejection of strychnine (+10 nA) .
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order to reach equilibrium conditions, and the overall 
effect was to increase the "dose" of glycine required to 
halve the firing rate of this neurone by a factor of 2.7.
If extracellular concentrations of glycine and strychnine 
attained during electrophoretic ejection can be compared on 
the basis of ejecting currents, the concentration of stry­
chnine required for this almost threefold reduction in gly­
cine sensitivity was approximately 0.5% of the glycine 
concentration.
The interaction between strychnine and glycine upon 
another interneurone is illustrated in Fig. 18. The cell 
was firing spontaneously at a rate of 18-20 spikes per sec­
ond and prior to the administration of strychnine, glycine, 
ejected with a current of +10 nA (retaining current -10 nA) , 
was just adequate to completely suppress this firing, the 
response to this amount of glycine (and to GABA) being slow 
because of the relatively large retaining current (Fig. 18A). 
Approximately 48% inhibition followed the ejection of glycine 
with a current of +5 nA. Strychnine, having been retained 
with an anionic current of 15 n A , was then administered with 
cationic currents which were increased in a step-wise manner 
from a micropipette containing 10 mM strychnine hydrochloride 
in 165 mM NaCl. Each "dose" level of strychnine was main­
tained for 5-6 minutes, and the amount of glycine required 
for just-maximal inhibition was then determined, together 
with an amount producing submaximal inhibition. Tracings 
of the effects of strychnine, +1 nA and +10 n A , are repro­
duced in Figs. 18 B and C respectively. The maximum current 
which could be passed through the glycine micropipette was 
+ 60 nA, and although th'e number of observations made was 
limited, the findings are consistent with those of Fig. 17, 
namely a displacement of the dose-response curve to the 
right by low concentrations of strychnine, rather than a 
diminution of the maximum effect of glycine. Again, on a
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comparison of electrophoretic currents, the concentration 
of strychnine abolishing the depressant effect of glycine 
(60 nA) was approximately 1% of that of glycine.
Similar results were obtained with all neurones so 
studied; in some, recovery and restoration of the dose-re­
sponse curve was also observed. In each case the reduction 
by strychnine of inhibition of firing by a particular "dose" 
of glycine could be restored by increasing the current used 
to eject the amino acid. However the maximum current which 
could be passed through glycine-containing barrels of 
60-100M resistance was often limited to 60-80 n A , and thus 
reliable information could not be obtained regarding the 
influence of relatively high concentrations of strychnine.
(ii) The effect of intravenously administered strychnine on 
the glycine dose-response curve.
Since strychnine administered in this fashion invari­
ably increased the spontaneous firing rate of spinal neurones 
and their sensitivity to excitants, control observations were 
made on neurones fired by DLH at rates slightly exceeding the 
spontaneous rate. Subsequent to the injection of strychnine, 
the amount of DLH ejected was then reduced to maintain a 
rate of firing similar to that of the control period. Re­
sults from one experiment are illustrated in Fig. 19. The
firing rate of this spinal interneurone was maintained at a 
frequency of 25 spikes per second, and two doses of stry­
chnine hydrochloride (each of 0.1 mg/kg) were administered 
intravenously. Such doses of strychnine, which would be 
expected to reduce but not abolish the synaptic inhibition 
of spinal neurones (Bradley, Easton and Eccles, 1953) , clear­
ly displaced the glycine dose-response curve to the right 
(Fig. 19 A ) . Throughout the period of observation the 
amplitude of the extrace 1lularly recorded action potentials 
was not altered, and neither these doses of strychnine 
(Fig. 19 B) nor an additional 0.2 mg/kg (not illustrated)
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The effect of intravenous strychnine on the 
dose-response curves of glycine and GABA. These curves 
plot the percentage inhibition of firing of a spinal 
interneurone, ordinate, against the current of the 
substance which produced this inhibition, on a logarithmic 
scale, abscissa. In the absence of depressants, the cell 
fired at 2 5 spikes/sec. in response to continually admi­
nistered DLH.
A. Curves obtained by the electrophoretic administration 
of glycine before strychnine (filled circles), after the 
intravenous administration of strychnine, 0.1 mg/kg 
(filled triangles) and after a further dose of strychnine, 
0.2 mg/kg i.v. (filled squares).
B. Curves from the electrophoretic administration of 
GABA to the same interneurone. The symbols correspond 
to those used for glycine but are unfilled.
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modified the sensitivity of the neurone to GABA.
In another experiment, glycine (0 nA) halved the spon­
taneous rate of firing of an interneurone (30-40 spikes/sec). 
This effect was abolished after the administration of 0.2 
mg/kg of strychnine hydrochloride. The reduction of the 
frequency of firing of a Renshaw cell from 80 spikes/sec to 
zero by glycine (+4 nA) was also effectively diminished in 
another animal by the same dose of strychnine, the rate 
being reduced from 80-90 spikes/sec to only 60-70/sec.
Similar results were obtained in two other experiments.
(iii) The effect of strychnine on the depression of spinal 
neurones by GABA
Detailed observations of the effect of strychnine on 
glycine and GABA dose-response curves were possible with only 
a few neurones, and the most usual experiment in both anaes­
thetised (27) and decerebrate non-anaesthetised (5) cats 
concerned the effects of strychnine on "doses" of glycine 
and GABA which were just adequate to suppress spontaneous or 
chemically evoked firing, and "doses" which had submaximal 
effects (30-60% inhibition) usually without obtaining suffi­
cient data to prepare dose-response curves.
One comparison of dose-response curves is illustrated 
in Fig. 17, A and B. The electrophoretic ejection of stry­
chnine (2 mM) with a current of +10 nA displaced the glycine 
curve to the right (Fig. 17 A ) . In contrast, the "doses" 
of GABA required for approximately 45% and 85% inhibition 
were not altered (Fig. 17 B ) . In the case of the neurone 
illustrated in Fig. 18, administration of strychnine (10 m M , 
+20 nA) abolished the depressant effect of a "dose" of 
glycine six times that initially required for just-total 
inhibition, whilst reducing the effect of +5 nA of GABA from 
approximately 66% inhibition to 47% inhibition: there was
no appreciable reduction in the rate of onset of depression 
by GABA. Throughout the period of strychnine administration
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+10 nA of GABA was sufficient to suppress completely the 
firing of this particular interneurone.
On the total number of spinal neurones tested (27 
interneurones, 26 Renshaw cells) , strychnine administered 
in amounts adequate to completely suppress the depressant 
action of glycine, reduced the action of initially equally 
effective amounts of GABA only on 3 neurones and by less 
than 20%. When the concentrations of strychnine were in­
creased, the action of GABA on 2 additional cells was re­
duced and slowed in onset, but was not abolished.
Several factors interfered with a complete assessment 
of the degree of selectivity of strychnine as an antagonist 
of glycine and GABA. Currents exceeding +80 nA could not 
be readily passed through glycine-containing micropipettes, 
and hence an estimate could not be made of how many times 
the "dose" of glycine needed to be increased in the pre­
sence of strychnine. Secondly, the direct excitation of 
neurones by relatively high concentrations of strychnine, 
and the depression of firing with alterations of the ampli­
tude and shape of the action potentials by even higher con­
centrations frequently limited the current used to eject 
this alkaloid, and hence presumably reduced the possibility 
of influencing the action of GABA. Thus, whilst it was 
clear in all experiments that strychnine was a highly 
specific glycine antagonist, the specificity could not be 
defined numerically with any great degree of confidence. 
Many cells were found in which a concentration of strych­
nine 15-20 times that abolishing the action of glycine was 
without effect on the action of GABA. For example, the 
firing of one interneurone was depressed to approximately 
20% of the initial rate by glycine (+5 nA) and GABA (+30 
nA). The effect of glycine was abolished when strychnine 
was ejected with +5 nA from a 2 mM solution. However,
64
the depressant action of GABA remained unaltered when stry­
chnine was administered from a 10 mM solution in another 
barrel of the micropipette with a current of +80 n A . Assu­
ming that a given electrophoretic current ejects approximate­
ly five times more strychnine from a 10 mM solution (both in 
165 mM NaCl), in this particular experiment strychnine was 
apparently more than 80 times less effective as a GABA anta­
gonist than as a glycine antagonist.
Intravenously administered strychnine was also tested 
as a possible GABA antagonist. In the case of the cell 
illustrated in Fig. 19 A and B, 0.2 mg/kg of strychnine 
hydrochloride displaced the glycine dose-response curve to 
the right, reducing the effect of glycine by a factor of 
approximately 3 (Fig. 19 A) without influencing the depres­
sant action of GABA (Fig. 19 B) . In another experiment 
0.8 mg/kg of strychnine hydrochloride, which reduced the 
effect of glycine upon an interneurone by a factor of 5, 
assessed on the "dose" of glycine for 50% inhibition, did 
not modify the effects of GABA. Larger doses of strych­
nine could not be administered because of changes in the 
excitability and firing pattern of the neurone being studied. 
Hence experiments of this type, while clearly establishing 
a difference between the susceptibility to strychnine of the 
effects of glycine and GABA, were not suitable for estimating 
the degree of specificity.
6 5
DISCUSSION
The parallel displacement of glycine d o s e - response 
curves both by intravenous, and e l e c t r o p h o r e t i c a l l y  a d m i n i ­
stered strychnine differs from the results obtained by Davi- 
doff et al. , (1969) . These authors pr o p o s e d  non-co m p e t i t i v e
a n t a go ni sm between strychnine and glycine on the basis of 
the failure of increased doses of glycine to overcome the 
effect of electroph o r e t i c a l l y  a d m i n i s t e r e d  strychnine, a 
finding reflected in non-parallel d i s p l a c e m e n t  of the glycine 
d o s e - re sponse curve and a reduction in the maximal effect 
atta ine d by glycine. In a ttempting to explain why these 
results differ from those ob tained in these experiments, it 
is first necessary to point out diff erences between curves 
obtai ne d in m i c r o e l e c t r o p h o r e t i c  expe riments and those o b ­
tained from a tissue perfused with or immersed in a solution 
con ta in ing the drug being studied.
In the latter type of experiment, d o s e - response curves 
are de ri ved under conditions in which a fixed number of r e ­
ceptors are exposed to drug mole cules uniformly d i s t r ibuted 
in the external medium. In contrast, when drugs are a d ­
mi ni s t e r e d  elect r o p h o r e t i c a l l y  from the 1-2 yM  orifice of a 
m i c r o p i p e t t e  located near a neurone, and the response is 
record ed either as an alteration in firing frequency (extra­
cel lul ar recording) or as a change in membrane potential, 
conduc tance or exci tability  (intracellular recording) , the 
fol lowing factors need to be considered.
(1) All of the neuronal membrane is not exposed to a u n i ­
form con cent ration of the drug. Because of their a t t a c h ­
ment to e x tracellular or intra c e l l u l a r  recording m i c r o ­
electrodes, drug a d ministering m i c r o p i p e t t e s  will be lo­
cated closer to the soma of neurones than to dendritic r e ­
gions. Drug concentrations will not be un iform around the 
soma and dendritic receptors will be ex posed to lower con-
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centrations than are those on the soma.
Alterations in nerve cell activity may arise from the 
involvement of, and perhaps saturation of, receptors upon 
membrane lying closest to the drug source, an area which may 
be a small fraction of the total neuronal surface. The ex­
tent of the membrane influenced will depend on the diffusion 
of the drug through the extraneuronal space, and processes 
of drug inactivation or removal from this space. More dis­
tant receptors will be exposed to lower concentrations which 
attain peak levels more slowly (Curtis, Perrin and Watkins, 
1960; Jaeger, 1965). Receptors far out on dendrites may 
even be unaffected by drugs administered electrophoretically 
Cell size and geometry may thus be an important factor in 
any assessment of drug effects on neurones.
(2) An increase in the rate of drug ejection raises the con 
centration in the vicinity of the proximal receptors, and, 
in addition, involves even more distant receptors which were 
previously unaffected by the drug. The response to increa­
sing doses (rates of drug ejection) thus encompasses an in­
creasing number of receptors exposed to the drug as well as 
an increasing concentration in the vicinity of some of the 
receptors.
A comparison of the sensitivity of different agonists 
to a given antagonist depends on the assumption that the 
appropriate receptors are similarly distributed in relation 
to the orifice of the micropipette from which the antagonist 
is ejected. The effect of a particular agent may not be 
influenced by an antagonist merely because the antagonist 
does not gain access to the appropriate receptor sites. 
Furthermore, an agonist may appear to surmount the influence 
of an antagonist because, with increasing rates of ejection, 
it gains access to more remote receptors which are unaffec­
ted by the antagonist, rather than by displacing antagonist 
molecules from receptors. Thus dose-response curves may
be displaced in a parallel fashion even in the presence of 
a non-competitive antagonist until all receptors on a neu­
rone are affected by the agonist.
(3) Alterations in firing rate of a neurone are largely 
determined by the membrane potential of the initial segment. 
Since receptors upon a neurone are not uniformly and simul­
taneously exposed to a drug, a given response may be achieved 
by drug effects having magnitudes inversely related to the 
proximity of the affected membrane to this segment. Thus, 
the effect on the firing frequency of an administered ex­
citant or depressant will usually be a combination of a re­
latively short latency action at membrane sites close to
the pipette, together with effects of smaller magnitude, 
which are less rapid in onset because of the time taken for 
the drug to diffuse to its site of action, but perhaps of 
equal effectiveness in altering the firing rate. Accord­
ingly, antagonism of receptors near the pipette orifice may 
merely slow the onset of the action of an agonist without 
incluencing its effect at equilibrium. Such antagonism 
would not be apparent if the dose-response relationship were 
evaluated only on the eventual equilibrium effect of a cer­
tain dose of agonist.
(4) The difficulties outlined above would be least likely 
when agonist and antagonist were administered from neigh­
bouring micropipettes at similar rates. However, a com­
plete analysis of the agonist - antagonist interaction re­
quires systemic administration of the latter, in order to 
achieve a more uniform pericellular concentration, provided 
that the substance passes through the "blood brain barrier", 
that it does not indirectly modify the activity of the neu­
rone under observation by influencing cells with which it
is synaptically connected, and that the amount administered 
is not limited by effects elsewhere in the experimental
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animal, as for example on the cardiovascular or pulmonary 
system. In addition, the possibility exists that a syste- 
mically administered antagonist of an electrophoretically 
administered agonist will be relatively ineffective in 
comparison with its action when ejected near neurones. In 
general, tissue concentrations attained after systemic in­
jection, although uniform, will be lower than those after 
local administration, particularly in the vicinity of the 
micropipette orifice. Hence difficulty may be experienced 
in demonstrating antagonism between two compounds, one ad­
ministered mi eroe1ectrophoretica1ly, the other systemica1ly, 
even though antagonism can be demonstrated readily when both 
are ejected from different barrels of a multibarrel micro­
pipette .
(5) Antagonists may have complex concentration-dependent 
effects on membranes and receptors, and relatively highly 
specific actions at receptors located at a distance from the 
micropipette orifice may be obscured by less specific 
effects at more proximal receptors subject to higher concen­
trations of the antagonist. Thus, if a family of dose-re­
sponse curves is obtained in which low concentrations of an 
antagonist produce parallel displacement and high concen­
trations reduce the maximum response attained, this does not 
necessarily indicate non-competitive antagonism, but could 
result from non-specific effects produced by high concentra­
tions of the antagonist in the vicinity of the tip of the 
micropipette. Again, systemic administration may be of 
advantage to achieve uniform and relatively low pericellular 
concentrations.
(6) In the absence of a direct measure of concentration, 
the "dose" is expressed as the rate of drug ejection.
Under equilibrium conditions the concentration at a given 
distance from the micropipette orifice is directly related
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to the ejecting current, and inversely related to the 
distance. The sensitivities of different neurones to a 
particular substance are not directly comparable, as the 
orifice-cell distance can neither be measured nor expressed 
in a simple manner because of the differing shapes and 
sizes of neurones and the relationship between current and 
rate of ejection of any one substance may vary, from one 
micropipette with changing conditions, and between different 
micropipettes.
(7) Under some conditions (drugs ejected as identical ions 
from solutions of the same ionic concentration, from micro­
pipettes of relatively low and stable electrical resistance) 
more or less meaningful comparisons are possible of the re­
lative effectiveness of a number of depressants, (or exci­
tants) , ejected from different barrels of a multibarrel 
micropipette assembly upon the one neurone, based on the 
currents required to achieve similar submaximal responses
by interaction with the same receptors. These findings can 
be related to experimentally determined values of transport 
numbers for the individual ions , and when carried out on a 
number of neurones of a particular type, provide a basis for 
a comparison with the action of the same substance on 
neurones of other types.
(8) A number of technical difficulties also need to be con­
sidered, including the maintenance of stable recording con­
ditions and a constant micropipette-neurone distance for a 
time adequate to complete a study of dose-response curves; 
difficulties inherent in measuring small effects, excitant 
or depressant, on a fluctuating "base-line", be it firing 
frequency or membrane parameters; limitations placed on the 
magnitude of electrophoretic currents, and hence on attain­
able drug concentrations, by the generation of electrical 
noise and fluctuation of micropipette resistance values;
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difficulty in determining the current corresponding to zero 
concentration since the diffusional efflux of drugs is con­
trolled by a retaining current which is usually excessive in 
order to reduce "after-diffusion" (del Castillo and Katz, 
1957); and problems arising from the uncontrolled diffusional 
efflux of antagonists, associated generally with the use of 
too highly concentrated solutions.
In general, therefore, dose-response relationships ob­
tained microelectrophoretica1ly probably reflect a balance 
between over-saturation effects at receptors close to the 
pipette orifice, near-saturation effects at receptors 
slightly further away, and minimal involvement of receptors 
at the periphery of the volume of tissue influenced by the 
ejected agent. The shape of the dose-response curve, and 
the effects of antagonists upon it, will be the result not 
only of the kinetics of drug-receptor interactions at indi­
vidual receptors, but also a complex function of the number 
of receptors involved and their spatial arrangement relative 
to the soma of the cell. In addition consideration should 
also be given to effects on cell function of alterations 
of extra- and intracellular ion concentration which may 
follow relatively prolonged activation of transmitter re­
ceptors .
In view of these factors, the parallel displacement 
of the glycine dose-response curve by increasing doses of 
strychnine is compatible with both competitive and non 
competitive antagonism as the doses of glycine used may not 
have resulted in an action at all of the glycine receptors 
on the neuronal membrane. Whilst it is true that when all 
glycine receptors are being activated, a non-competitive 
antagonist will then produce a non parallel displacement of 
the glycine dose response curve with a diminution of the 
of the maximum response, a competitive antagonist could have
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the same effect through a non-specific action produced by 
high concentrations in the vicinity of the tip of the micro­
pipette .
It is possible that the results obtained by Davidoff 
et a l ., (1969) stem from this latter mechanism. The cell 
illustrated by these authors had a mean firing rate of 46 
spikes/sec in response to the continuous ejection of 
L-glutamate (62 nA), but required 100 nA of glycine to pro­
duce 80% depression of firing in the control period. In 
relation to its sensitivity to glutamate, this cell was 
markedly insensitive to glycine, which suggests that stry­
chnine had been leaking from the pipette prior to the 
control observations. The active ejection of further amounts 
of strychnine may have produced concentrations having non­
specific effects (discussed below) and these reduced the 
action of both glycine and GABA.
Thus, controversy over the usefulness of strychnine 
as an aid to transmitter identification depends on which 
effects observed with varying amounts of electrophoretica1ly 
administered strychnine are relevant to the reduction of 
inhibitory post-synaptic potentials observed with just- 
convulsant doses of strychnine. All investigators have 
found that strychnine administered electrophoretically blocks 
the action of simultaneously administered glycine. However, 
higher concentrations than those blocking the action of 
glycine have been reported to antagonize the depressant 
action of GABA (Davidoff et al. , 1969; Johnson et al. , 1970) ,
dopamine, and noradrenaline (Phillis and York, 1967; Phillis 
and Tebecis, 1967; Tebecis, 1967 , 1970) . The effects of
strychnine when applied either topically or electrophoret- 
ically to a variety of neural tissues are concentration- 
dependant. When directly applied to nerve fibres, stry- 
ghnine increases excitability and in high concentration has
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a stabilising effect similar to that of local anaesthetics 
(Coppee and Coppee - Bolly 1941, Erlanger, Blair and Schoe- 
pfle, 1941; Alving, 1961) . Electrophoretically administered 
strychnine initially excites, and with high concentrations 
subsequently depresses, many different types of central neu­
rone including Purkinje cells (Crawford, Curtis, Voorhoeve 
and Wilson, 1963) , cerebral cortical neurones (Krnjevic 
et al., 1966; Biscoe Curtis, 1967; Phillis and York, 1967,
Johnson, et al. , 1970) , thalamic neurones (Phillis and Te- 
becis, 1967) and spinal neurones (Curtis, 1967; Curtis 
et al., 1968 a,b). These higher dose effects are normally 
accompanied by a reduction in amplitude of extracellularly 
recorded action potentials, and the concentrations are in 
excess of those needed to reduce the sensitivity of neurones 
to electrophoretically administered glycine, and to reduce 
spinal inhibitory post-synaptic potentials (Curtis, 1962; 
Curtis et al., 1968 a,b).
Administered intravenously subconvulsive doses of stry­
chnine which diminish the amplitude of intrace 1lularly 
recorded recurrent and "direct" inhibitory potentials of 
spinal motoneurones, neither depolarize these cells, alter 
the membrane resistance nor influence excitatory synaptic 
transmission (Eccles and Fatt and Koketsu, 1954; Coombs, 
Eccles and Fatt, 1955; Curtis, 1962; Fuortes and Nelson,
1963; Araki, 1965; Curtis et al., 1968 a,b; Larson, 1969). 
Hence it is likely that the effect of relatively low con­
centrations of strychnine on inhibiton in the spinal cord 
(Bradley et al., 1953) and medulla (Morimoto, Takata and 
Kawamura, 1968) can be explained in terms of a relatively 
specific action at inhibitory synapses.
An interference with inhibitory synapses could be 
brought about by an effect on the firing of inhibitory 
interneurones, a reduction in the amount of inhibitory 
transmitter released, competition with the inhibitory
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transmitter for a receptor or reduction of the ionic con­
ductance changes which underly the inhibitory postsynaptic 
potent!als.
Convulsant doses of strychnine do not affect the firing 
of inhibitory interneurones of either the "direct" or re­
current pathways to motoneurones (Eccles et a l ., 1954;
Curtis, 1962, 1967; Larson, 1969) . A reduction in the amount 
of transmitter released could result from an inhibiton of 
synthesis or an interference with release of normal stores. 
Suppre s sion of transmitter synthesis is unlikely since the 
latency of strychnine action is extremely short. McKinstry 
and Koelle (1967) proposed that inhibitory nerve terminals 
first released acetylcholine which in turn caused release 
of inhibitory transmitter and that strychnine interfered 
with the action of acetylcholine. This complex process is 
rendered unlikely by the finding that concentrations of 
strychnine adequate to suppress the inhibition of Renshaw 
cells facilitates transmission at the cholinergic axon 
collateral terminals which excite these neurones (Curtis,
1967) .
Strychnine may reduce the amount of transmitter released 
from spinal inhibitory nerve terminals, but such a proposi­
tion becomes less tenable when considered in relation to 
neurochemical and physiological evidence that glycine could 
be the transmitter at these inhibitory synapses (Werman, 
Davidoff and Aprison, 1968; Curtis, et al., 1968 a,b; Apri- 
son and Werman, 1968; Curtis and Johnston, 1970; Hebb , 1970) .
Since both glycine and the inhibitory transmitter appear 
to produce an identical change in postsynaptic membrane 
permeability it seems reasonable to conclude that glycine 
receptors on spinal neurones could be identical with those 
activated by the transmitter, and that strychnine inter­
feres with the action of glycine and the transmitter by a 
common mechanism. Although strychnine could combine with
glycine on a molecular basis, effectively reducing the sub- 
synaptic concentration of the amino acid, the inhibitory 
action of glycine is blocked by much lower concentrations 
of the alkaloid, generally of the order of less than 1% if 
extracellular concentrations can be compared on the basis 
of measured electrophoretic currents. Furthermore, physico­
chemical studies in vitro have provided no evidence for the 
existence of stable glycine-strychnine complexes other than 
simple salts (Johnston, unpublished). Thus the action of 
strychnine is most probably confined to the postsynaptic in­
hibitory membrane.
Several observations suggest that concentrations of 
strychnine adequate to reduce spinal postsynaptic inhibition 
and the effects of glycine, do not modify the nature of the 
ionic conductance change induced in the postsynaptic mem­
brane. Thus both hyperpolarizing and depolarizing inhibi­
tory potentials (depolarizing after manipulation of intra­
cellular ion concentrations) are blocked by strychnine 
(Coombs et al. , 1955; Curtis et a l . , 1968b; Larson, 1969);
the "reversal" potential for the inhibitory potential is not 
altered by strychnine (Larson, 1969); and although both 
glycine and GABA apparently induce the same change in ionic 
permeability the action of glycine is much more sensitive to 
strychnine than that of GABA (Curtis et al. , 1968a,b; Larson,
1969) . Higher concentrations of strychnine may interfere 
with or even alter the nature of the change in ionic per­
meability (Araki, 1965; Pollen and Lux, 1966) , providing in 
part an explanation for the modification of the inhibitory 
effects of GABA, DA and NA on a variety of central neurones 
(Phillis and York, 1967; Phillis and Tebecis, 1967; Tebecis, 
1967, 1970; Davidoff et al., 1969; Johnson et al., 1970),
and even higher concentrations may involve changes in sodium 
permeability accounting for excitation and depression of 
nerve cell activity.
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The parallel displacement of the glycine d o s e -response 
curve by strychnine administered i n travenously is consistent 
with, but by no means establishes strychnine as a competitive 
anta gon ist of glycine. Full analysis of the type of a n t a ­
gonism  would require the use of much higher doses of the 
alkaloid (Ariens, Simonis and van Rossum, 1964) , for example 
det er mi nation of doses giving pA 2 and pA 10 values. H o w ­
ever this was prec luded by the increase in neuronal e x c i t a ­
bility which followed doses of strychnine exceeding 0.1-0.2 
mg/kg, and by limitations usually expe r i e n c e d  in the amount 
of glycine which could be a d m i n i s t e r e d  e l e c t r o p h o r e t i c a l l y .
As these effects on the action of glycine were obtained  
with sub- and just-convulsive doses of strychnine, doses 
which reduce inhibitory p o s t s y n a p t i c  p otentials in the spinal 
cord, the antagonism of the action of glycine by e l e c t r o ­
ph or e t i c a l l y  administered strychnine is clearly relevant 
to the i d entification of an inhi bitory transmitter. M o r e ­
over, the findings of Roper et a 1 . (1969) , that inhibition
of the Mauthner cell of the goldfish was abolished by s y s t e ­
mic strychnine prior to any change in the effectiveness of 
e l e c t r o p h o r e t i c a l l y  a d m i n istered glycine, cannot be applied 
to the spinal cord of the cat.
A major aim of this study was to establish whether the 
specificity of strychnine as a glycine anta gonist was 
suff ici ently high to justify its use in d e t e rmining the 
nature of the transmitter at inhibitory synapses. Because 
of the complexities involved in studying the amino acid 
sensit ivity of single neurones, an accurate figure cannot 
be given for the c o n c e n tration range over which strychnine 
dis cr im inates between receptors for glycine (and glycine-like 
amino acids) and for the other d e p r e ssants studied, but an 
estimate of 10-100 seems not unreasonable. Since c o n c e n ­
trations of strychnine many times those necessary to c o m ­
plet ely  block the action of glycine m e rely reduce the action
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of GABA, noradrenaline and dopamine in microelectrophoretic 
experiments, it is likely that these latter effects result 
from modification of membrance permeability changes rather 
than an action at the receptors for these compounds. The 
degree of specificity determined for strychnine in differ­
entiating between glycine-like amino acids and these other 
compounds, together with the results obtained from the intra­
venous administration of strychnine, makes it improbable that 
the interference by high concentrations of strychnine with 
the action of GABA, dopamine and noradrenaline is of relevance 
to the reduction of inhibitory postsynaptic potentials by 
just convulsive doses of strychnine, and that strychnine in 
these concentrations is sufficiently specific in its action 
to indicate that glycine or a glycine-like amino acid is 
operating at these synapses.
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VII. B1CUCULLINE, GABA AND CENTRAL INHIBITION
Since y-aminobutyric acid (GABA) was first detected 
in extracts of nervous tissue (Roberts and Frankel, 1950; 
Awapara, Landau, Fuerst and Seale, 1950) , this amino acid 
has had an "unproven" status as an inhibitory transmitter 
within the mammalian central nervous system. A possible 
role as a transmitter was suggested by its isolation from 
Factor I (Bazemore, Elliott and Florey, 1957), and the 
demonstration that GABA was 500 times more active than 
Factor I in inhibiting the slowly adapting crayfish stretch 
receptor. GABA was soon shown to have depressant effects 
on diverse parts of the central nervous system when admini­
stered topically, systemically or into the cerebrospinal 
fluid (reviewed by Curtis and Watkins, 1965) .
When administered electrophoretically from the outer 
barrel of co-axial micropipettes to spinal motoneurones 
(Curtis, Phillis and Watkins, 1959) GABA was a potent de­
pressant, increased membrane conductance, diminished in­
hibitory and excitatory postsynaptic potentials, blocked 
antidromic invasion, but hyperpolarization of the membrane 
was not detected. This observation seemed to exclude GABA 
as an inhibitory transmitter acting on motoneurones. GABA 
was also found not to hyperpolarize cerebral cortical neu­
rones (Krnjevic, 1964) when administered from co-axial 
micropipettes.
A hyperpo1arization of neurones by GABA was first shown 
in Deiters' nucleus, (Obata, 1965; Obata, Ito, Ochi and 
Sato, 1967). In these experiments co-axial micropipettes 
were also used, and the difference between these findings 
and those previously obtained on motoneurones and cortical 
neurones has not been satisfactorily explained. A re­
examination of the action of GABA on cortical neurones 
(Krnjevic and Schwartz, 1967) and motoneurones (Curtis,
Hosli, Johnston, and Johnson, 1968a) using parallel micro- 
pipettes has revealed a hyperpolarizing action.
Picrotoxin is an effective antagonist of GABA at the 
crayfish inhibitory nerve-muscle synapse (Robbins and van 
der Kloot, 1958) , abdominal stretch receptor (Elliott and 
Florey, 1956) and heart (Florey, 1957). A recent analysis 
of the effects of picrotoxin at GABA receptors (Takeuchi and 
Takeuchi, 1969) indicates that the dose-response curves for
GABA at the crustacean neuromuscular junction in the presence 
of increasing concentrations of picrotoxin are not parallel, 
suggesting non-competitive antagonism between the two com­
pounds. These authors propose either irreversible binding 
of picrotoxin to membrane components or an action on membrane 
structures associated with the inhibitory potential other 
than the GABA receptor.
In contrast to the literature on Crustacea, reports of 
the influence of picrotoxin on the action of GABA in the 
mammalian central nervous system are conflicting. Admini­
stered electrophoretica 1ly picrotoxin has been claimed to:-
(1) Have no effect on the action of glycine or GABA on 
spinal interneurones when passed as an anion or a cation 
(Curtis, Hosli and Johnston, 1968b).
(2) Occasionally slightly reduce the action of both glycine 
and GABA on spinal interneurones (Curtis, Duggan and Johnston, 
196 9) .
(3) Block the action of glycine on spinal interneurones 
(Davidoff and Aprison, 1969).
(4) Block the action of GABA but not that of glycine on 
neurones of the cuneate nucleus (Galindo, 1969).
(5) Block the action of GABA but not that of glycine on 
"an important fraction" of cells of Deiters' nucleus 
(Bruggencate and Engberg, 1969) .
(6) Block the action of GABA but not that of glycine on
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15% of spinal interneurones (Engberg and Thaller, 1970).
(7) Block the action of GABA but not that of glycine on 
oculomotor neurones (Obata and Highstein, 1970).
Davidoff and A p n s o n  (1969) , attempted to explain the 
earlier negative results of Curtis et al. (1968a) in terms 
of inactivation of picrotoxin by the high pH of the solutions 
used. This is not a complete explanation as the observa­
tions of Curtis et al., were made with both acidic and alka­
line solutions. Furthermore, solutions prepared in a manner 
identical to that of Davidoff and A p n s o n  and including a 
sample of the latters' picrotoxin were used in the subsequent 
experiments of Curtis et al. (1969).
When both substances are administered by close intra­
arterial injection, picrotoxin has been shown to block the 
depressant effect of GABA on transmission in autonomic 
ganglia (de Groat, 1970) . No specificity was shown in this 
preparation as all amino acids found to block transmission 
(GABA, ß -hydroxyGABA, 3-alanine, 3-aminopropane sulphonic 
acid) were antagonized by picrotoxin. Glycine had no effect 
on transmission.
The possibility of antagonism between GABA and picro­
toxin is of importance to the numerous inhibitions in the cat 
that are influenced by intravenously administered picrotoxin. 
These include:-
(1) Presynaptic inhibition of reflexes by impulses in 
muscle afferent fibres within the spinal cord (Eccles,
Schmidt and Willis, 1963) - 0.1-1.0 mg/kg.
(2) "Strychnine-insensitive" spinal post synaptic inhibition
(Kellerth and Szumski, 1966) - 1.0 mg/kg.
(3) Postsynaptic inhibition of oculomotor neurones by
stimulation of the vestibular nerve (Ito, Highstein and 
Tsuchiya, 1970) - 12.0 mg/kg.
(4) Inhibition of vestibular neurones following stimulation
of the flocculus (Ito, Highstein and Fukuda, 1970) - 10 mg/kg.
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(5) Postsynaptic inhibition of Deiters' neurones by impulses
in Purkinje cell axons from the anterior lobe of the cere­
bellum (Obata, Takeda and Shinozaki, 1970) - 5-10.0 mg/kg;
smaller doses being ineffective (Obata, Ito, Ochi and Sato, 
1967) .
(6) Presynaptic inhibition in the cuneate nucleus (Banna
and Jabbur, 1969) - 0.5-1.6 mg/kg.
This situation is made more complex by the failure of 
picrotoxin administered intravenously (0.2-0.6 mg/kg) and 
electrophoretically to influence the inhibition of deep pyra­
midal cells produced by stimulation of the cerebral cortical 
surface (Krnjevic, Randic and Straughan, 1966) , an inhibition 
for which GABA has been proposed as the transmitter (Krnjevic 
and Schwartz, 1967) .
Electrophoretically administered picrotoxin has been 
claimed to block the inhibition of rabbit oculomotor neurones 
by impulses in the vestibular nerve, a finding paralleled by 
a block of GABA action on these cells (Obata and Highstein, 
1970) .
In view of the conflicting reports outlined above, 
picrotoxin can hardly be regarded as a satisfactory and 
specific GABA anatgonist within the mammalian central nervous 
system. The doses of picrotoxin used in the recent papers 
of the Japanese workers are well above those necessary to 
produce convulsions (1-2 mg/kg). Moreover the nature of 
this compound limits its usefulness in microelectrophoretic 
investigations which rely on a high degree of ionisation in 
the solution within the micropipette.
To be a useful aid in determining at which synapses 
GABA may be an inhibitory transmitter, a substance is 
needed which consistently and specifically blocks the action 
of GABA when both are administered electrophoretically, and 
which reduces the appropriate synaptic inhibition in sub-
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and just-convulsive doses. Picrotoxin does not meet any of 
these criteria.
Theoretical considerations of the manner by which stry­
chnine-like substances may occupy glycine receptors (Batter- 
ham and Johnston, unpublished) led to the proposal that a 
number of other convulsant alkaloids may be of interest as 
potential antagonists of GABA receptors. Among those ori­
ginally proposed were bicuculline, hydrastine, laudanosine 
and narcotine. Of these substances bicuculline is the most 
potent convulsant (Henry, 1949) , an amount of 0.2 mg/kg 
producing convulsions in the rabbit (Welch and Henderson, 
1934). The latter authors found that the convulsant dose 
of hydrastine in rabbits was 5-20 mg, intravenously.
Bicuculline is a phthalide isoquinoline isolated by 
Manske (1932, 1965) from species of Corydalis and Dicentra.
Hydrastine, a phthalide isoquinoline derived from Ranun- 
culacea species (Henry, 1949) has had limited use in the 
treatment of post partum haemorrhage as it causes contrac­
tion of the myometrium. Narcotine and laudanosine are 
both benzylisoquinoline alkaloids derived from opium. The 
structures of all four of these compounds are shown in 
Fig. 20.
When the initial experiments on spinal neurones showed 
that bicuculline was an antagonist of amino acids previously 
classified as "GABA-like" (Curtis et al., 1968a), but was
without effect on the action of "glycine-like" amino acids, 
a division made on the basis of antagonism by strychnine, 
it was realized that the effect of bicuculline on known 
strychnine resistant inhibitions throughout the central 
nervous system should be examined. Accordingly a syste­
matic study was commenced and the effects of bicuculline in 
Deiters' nucleus and in the thalamus, together with the 




The structures of bicuculline, laudanosine,
narcotine and hydrastine
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The inhibition of Deiters' neurones by impulses in 
Purkinje cell axons (Ito and Yoshida, 1964) is resistant to
intravenous strychnine, 0.3 mg/kg (Obata et a 1 . , 1967).
GABA administered e 1 e c t r opho r e t i c a 1 ly hyperpolarizes Dei-- 
ter's neurones (Obata et a1 . , 1967; Bruggencatc and Engberg,
1969) and the amino acid is released into the cat's fourth 
ventricle on stimulation of Purkinje cells (Obata and Takeda, 
1969) .
Isolated single Purkinje cells have a high content of 
GABA when compared with spinal neurones (Obata, 1969) , al­
though it is not know if this high level is contained within 
the cell body or within the synaptic endings attached to its 
surface. The cerebellum projects predominantly to the dor­
sal half of Deiters nucleus (Brodal, Pompeiano and Walberg, 
1962) and higher levels of glutamate decarboxylase (GAD), 
an enzyme associated with the synthesis of GABA, are found 
in the dorsal than in the ventral half (Fonnum, Storm-Mathi- 
son and Walberg, 1970). Moreover, destruction of the anter­
ior cerebellum reduces the concentration of GAD in the dorsal 
portion of the nucleus by 50-70% without affecting that of 
the ventral half (Fonnum, et al. , 1970) . Collectively this
evidence strongly favours GABA as the inhibitory transmitter 
released by Purkinje cell axons onto Deiters' neurones and 
hence a study of the action of bicuculline at these synapses 
was performed.
Thalamocortical relay neurones of the ventrobasal thala­
mus commonly respond to a peripheral nerve stimulus with a 
series of bursts of action potentials with intervening silent 
periods, the frequency of the bursts being about 10/sec 
(Adrian, 1941; Andersen, Brooks, Eccles and Sears, 1964). 
These bursts and silent periods correspond to alternating 
excitatory and inhibitory postsynaptic potentials (Andersen 
and Eccles, 1962 ; Andersen, Eccles and Sears, 1964) , a pheno­
mena also observed in cells of specific thalamic nuclei
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during their recruitment by low frequency stimulation of the 
nonspecific thalamic nuclei (Purpura and Cohen, 1962) . A 
recurrent inhibitory mechanism has been proposed to account 
for these inhibitory postsynaptic potentials (Andersen and 
Eccles, 1962 ; Andersen, et a1 . , 1964) , This synaptic pro­
cess has been reported to be insensitive to intravenous 
strychnine (Andersen, Eccles, L0yning and Voorhoeve, 1963)
and hence it was of interest to determine the effects of 




(a) Spinal reflexes. Bicuculline, given intraven­
ously produced convulsions in lightly barbiturate an­
aesthetised cats with doses of 0.2-0.5 mg/kg. These 
doses however had no effect on the following spinal 
inhibitions.
(1) Direct inhibition: the inhibition of BST
monosynaptic reflexes by volleys in the low­
est threshold afferent fibres of the quadri­
ceps nerve (4 cats) .
(2) The inhibiton of gastrocnemius monosynaptic 
reflexes by volleys in quadriceps or flexor 
digitorum longus (FDL) afferent fibres using 
stimuli four times threshold (4 cats) .
Unlike strychnine, bicuculline had minimal effect 
on the spontaneous activity recorded from ventral roots, 
the amplitude of monosynaptic reflexes evoked by stimu­
lating muscle afferents or polysynaptic reflexes in re­
sponse to stimulation of cutaneous afferents.
(b) Bicuculline and electrophoretically administered 
depressants. Administered alectrophoretically bicu­
culline was a reversible antagonist of the action of 
GABA, 3-hydroxyGABA (GABOB), 6-amino valeric acid, mus­
cimol and imidazole acetic acid, but was without effect 
on the action of glycine, 3-alanine, L-a-alanine, D-ot- 
alanine, taurine and nor-adrenaline.
(1) Glycine and GABA
Results comparing the action of glycine and GABA 
were obtained on 61 cells (39 interneurones, 22 
Renshaw cells) and with all but 6 interneurones, 
bicuculline reduced the inhibition by GABA of spon­
taneous or DLH induced firing without modifying that 
produced by glycine. Each of the six neurones in
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which bicuculline did not antagonize the action 
of GABA was relatively insensitive to the amino 
acid, currents of 20-30 nA being required to 
produce a complete inhibition of firing. More­
over, the currents of bicuculline used with 
these cells were less than 100 n A , and analy­
sis of the results obtained from the other 55 
cells indicated that higher bicuculline curr­
ents would have been more likely to reduce the 
action of these amounts of GABA. Although 
there was considerable variation, roughly 4-6 
times the current of GABA administered to any 
cell needed to be passed from the bicuculline 
solutions to produce antagonism.
Figure 21 illustrates the reversible and 
specific antagonism of GABA and glycine by 
bicuculline and strychnine respectively. The 
firing rate of this Renshaw cell was maintained 
at a constant level by the continuous ejection 
of DLH (15 nA initially, and adjusted when 
necessary). Approximately 75% depression of 
firing was produced by the ejection of glycine 
(5 nA) and GABA (8 nA). Bicuculline (40 nA 
from a 5 mM in 165 mM NaCl solution) reduced 
the effectiveness of GABA by about 60% with­
out having any significant effect on the action 
of glycine. Recovery of the GABA effect was 
complete withinin one minute of terminating 
the ejection of bicuculline with a current of 
50 nA (not illustrated). In contrast, ad­
ministration of strychnine (40 nA from a 2 mM 
in 165 mM NaCl solution - Fig. 21 B ) , com­
pletely blocked the action of glycine without 







Effects of bicuculline and strychnine on the 
inhibition of a Renshaw cell by glycine and GABA. The 
firing rate was maintained by the continual ejection of 
DLH (l5 nA). Glycine (5 nA), broken horizontal lines, 
and GABA (8 nA), dotted horizontal lines, were ejected 
at regular intervals, the ejections beginning at the 
time of the broken or dotted vertical lines. Bicuculline 
(Z4O nA) and strychnine (^0 nA) were ejected for the times 
indicated by the horizontal bars.
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Bicuculline and GABA dose-response curves.
The difficulties in obtaining and inter­
preting such curves when obtained from micro- 
electrophoretic experiments have been outlined 
previously in this Thesis. However, as a 
failure to observe a parallel displacement of 
the GABA dose-response curve in the presence 
of increasing concentrations of bicuculline 
would constitute evidence against competitive 
antagonism between these substances, several 
experiments were performed.
Dose response curves from one experiment 
are plotted in Fig. 22. The firing rate of 
this spinal interneurone was maintained at 
approximately 35 spikes per second by continu­
ously administered DLH and the response (ordi­
nate) is the percentage decrease of this rate 
produced by the electrophoretic ejection of 
the depressant amino acids until maximal in­
hibition was achieved for that particular 
ejecting current. As for the curves compiked 
for strychnine (Fig. 17), zero for the abscissa 
is the value of the retaining current for the 
substance being considered. Hence for a re­
taining current of -9 nA, ejection of +2 nA 
is plotted as a "dose" of 11 nA. Four series 
of curves are plotted from results obtained 
before (asterisks), during (filled symbols) 
and after (open symbols) the administration of 
bicuculline with cationic currents of 80, 180
and 240 n A , for periods of 8 1/2 to 10 minutes 
until a maximal effect on the action of GABA 
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Fig. 22
The effect of bicuculline on the dose response 
curves of glycine and GABA.
Ordinate: Percentage inhibition of the firing of a spinal
interneurone (35 spikes/sec in response to continuously 
administered DLH).
Abscissa: Current of the depressant amino acid adminis­
tered electrophoretically (nA, log scale). Unfilled
symbols, control observations; filled symbols, during the 
electrophoretic administration of bicuculline; circles,
80 nA; triangles, 180 nA; squares, 2U0 nA.
A# Curves from the electrophoretic administration of GABA.
B. Curves from the electrophoretic administration of
glycine•
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bicuculline, recovery was rapid (within 2-3 
minutes) as indicated by the corresponding 
closed and open symbols. Bicuculline pro­
duced a roughly parallel displacement of the 
GABA dose-response curve without modifying 
that of glycine.
Bicuculline was also administered intra­
venously in an attempt to influence the dose 
response curve of electrophoretica1ly admini­
stered GABA. Considerable technical diffi­
culties were experienced in these experiments, 
the main difficulty being to maintaining con­
stancy of spike amplitude, presumably because 
of swelling of the spinal tissue consequent 
upon the elevation in blood pressure invaria­
bly seen after the administration of relatively 
large doses of bicuculline. It was antici­
pated that large doses of bicuculline would 
be needed to observe any change in the effect­
iveness of GABA and such a change was seen in 
only one of four experiments performed. In 
this experiment the action of glycine on a 
Renshaw cell was not altered after 2 mg/kg of 
bicuculline had been given intravenously,- 
whereas the effect of GABA was reduced from 
95% to 65% inhibition.
( 2) Other substances
The action of bicuculline on the depress­
ant action of 3-alanine and of GABA was studied 
in 15 neurones (12 inter-neurones, 3 Renshaw 
cells) and in 14 of these, bicuculline blocked 
or depressed the action of GABA without affec­
ting that of 3-alanine. Effects by bicuculline
88
were not seen in the remaining cell. Fig.
23 A, illustrates results obtained from one 
Renshaw cell. Near maximal inhibition of 
firing was produced by GABA (5 nA) and ß-ala- 
nine (15 nA). Bicuculline (30 nA) reduced 
the action of GABA, 50 nA of bicuculline abo­
lished it, but the action of ß-alanine was 
unaffected. Similar results were obtained 
with L-a-alanine (1 interneurone) and taurine 
(3 interneurones). Fig. 23 B illustrates 
the depression of firing of an interneurone 
by GABA (40 nA) and taurine (45 n A , ejected 
as a cation from a solution of pH8). Bi­
cuculline (100 nA) completely suppressed the 
action of GABA but was without effect on that 
of taurine.
Bicuculline was an effective antagonist 
of the action of ß-hydroxy GABA (2 interneu­
rones) , muscimol (4 interneurones) and imida­
zole acetic acid (2 interneurones), and in 
general lower amounts were required to block 
the action of muscimol and imidazole acetic 
acid than were necessary to antagonize that 
of GABA. Fig. 24 A contains results obtained 
from an interneurone, and shows that muscimol 
(-1 nA) was a potent depressant and that its 
action was entirely suppressed by bicuculline 
(30 nA), whilst that of GABA (20 nA) was mere­
ly slightly reduced. Fig. 24 B, from another 
interneurone illustrates that bicuculline 
(60 nA) had very little effect on the action 
of GABA (2 n A ) , merely slowing its rate of on­
set, whereas that of imidazole acetic acid was
A . . .  ß-ALAN IN E 15 
_  GABA 5
BICUCULLINE 30
60
........  TAURINE 45
_  GABA 40 BICUCULLINE 100
Fig. 23
A. The effect of bicuculline on the depression of firing
of a Renshaw cell by GABA and ß—alanine. ß—Alanine
(l5 nA) , broken horizontal lines, and GABA (5 nA), solid 
horizontal lines were ejected at regular intervals. The 
commencement and cessation of bicuculline ejection 
(30 nA for 2 mins, 60 nA for mins), horizontal bar, is 
indicated by the vertical broken lines.
B. The effect of bicuculline on the depression of firing 
of a spinal interneurone by GABA and taurine. The 
ejection of GABA (UO nA) and taurine (I» 5 nA) is indicated 
by solid and dotted horizontal lines respectively,
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The effect of bicuculline and strychnine on the 
depression of a spinal interneurone by glycine, GABA, 
muscimol and imidazole acetic acid.
A. The ejection of muscimol and GABA is marked by inter­
rupted and solid horizontal lines respectively, that of 
bicuculline by a thick horizontal line , the onset and 
cessation of ejection being marked by broken vertical lines.
B. As for A, the ejection of imidazole acetic acid being 
marked by broken horizontal lines.
C. The ejection of glycine and imidazole acetic acid is 
marked by finely broken and coarsely broken horizontal lines 
respectivelly, that of strychnine by a thick horizontal line.
The numbers adjacent to each substance refer to 
the current used and are expressed in nA.
A _ _  GABA 13
. . .  nor-ADRENALINE 25
The effect of bicuculline on the depression of a 
spinal interneurone by GABA and nor—adrenaline.
The ejection of GABA (l3 nA) and nor-adrenaline 
(25 nA) is marked by solid and broken horizontal lines 
respectively, that of bicuculline by a thick horizontal 
line .
A. Control observations.
B. During the ejection of bicuculline 60 nA and 80 nA,
the commencement of the higher current of bicuculline being 
marked by a vertical broken line.
C. Recovery.
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markedly reduced . Fig. 24 C derived from the 
same cell illustrates that strychnine (10 nA) 
which completely blocked the action of glycine, 
had no effect on that of imidazole acetic acid.
Bicuculline in the doses used was not an 
antagonist of the depressant action of nor­
adrenaline on spinal neurones. Fig. 25 A 
is composed of control observations obtained 
from an interneurone and the "slow-on, slow 
off" type of response to nor-adrenaline (25 
nA) was usual with this substance. Bicucul­
line (80 nA) completely blocked the action of 
GABA (13 nA) Fig. 25 B, without altering that 
of nor-adrenaline. Recovery is shown in 
Fig. 25 C.
( ii) Deiters1 nucleus
(a) Bicuculline and the action of depressant amino 
acids.
When currents 5 to 10 times those used to eject 
GABA were passed through solutions of bicuculline (5 mM 
in 165 mM NaCl) , the action of GABA upon Deiters' neu­
rones was consistently reduced or abolished without any 
effect on that of glycine. When only lesser amounts 
of bicuculline in relation to those of GABA could be 
passed, the antagonism of GABA was unpredictable and 
varied from cell to cell. Antagonism was seen in 9 
of 13 cells tested, and in 3 of the remaining four the 
maximum bicuculline current which could be used was 
less than three times that of GABA. 3-Alanine was 
tested with glycine and GABA on three cells, and doses 
of bicuculline adequate to block the action of GABA 
reduced that of 3-alanine in two.
Strychnine, by contrast, completely blocked the
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action of glycine, had no effect on the action of GABA, 
and whilst doses greater than those adequate to block 
the action of glycine slightly reduced the action of 
3-alanine in one cell, no convincing antagonism of this 
amino acid was observed.
Fig. 26 illustrates these actions. This Deiters 
neurone was fired by the continuous ejection of DLH. 
Approximately 80% depression of firing was produced by 
GABA (8 nA), glycine (12 nA) and by 3-alanine (35 nA). 
Bicuculline (80 nA), (Fig. 26 A ) , markedly reduced the 
action of GABA, slightly reduced that of 3-alanine but 
had no effect on the action of glycine, whereas stry­
chnine (10 nA from a 10 mM in 165 mM NaCl solution),
(Fig. 26 B ) , abolished the action of glycine but had no 
effect on the action of the other amino acids. The 
actions of both alkaloids were reversible.
Fig. 27 illustrates blockade by bicuculline and 
strychnine of the effect of GABA and glycine respec­
tively in suppressing antidromic invasion of Deiters' 
neurones by stimulating the vestibulospinal tract at 
the ventral surface of the cervical spinal cord.
The columns labelled "C" contain a number of control 
responses each consisting of an antidromic "field" 
potential. Ejection of GABA (35 nA) and glycine (25 
nA) reduced the amplitude of this potential, as shown 
in row A. During the ejection of bicuculline (70 nA 
for 90 sec) the action of GABA was blocked, but that 
of glycine unaffected (row B ) . Conversely, strychnine 
ejection (20 nA for 80 Sec) blocked the action of 
glycine, without changing that of GABA (row C) . Re­
covery is depicted in row D.
(b ) Bicuculline and the inhibition of Deiters' neurones 
by impulses from the anterior cerebellum.
The inhibitory test used was blockade of antidromic
AFig, 26
A. The effect of bicuculline on the inhibition of a 
Deiters' neurone by GABA, glycine and ß-alanine. The 
time of administration of each amino acid is indicated
by a horizontal line underlying a square for GABA (8 n A ), 
a triangle for glycine (l2 nA) and a circle for ß-alanine 
(35 nA). The first record contains control observations, 
the second during the electrophoretic ejection of 
bicuculline (80 n A ), and the third after the cessation 
of ejection of bicuculline.
B. As for A, the middle records being obtained during 
the electrophoretic ejection of strychnine (lO nA).
A
GLYCINE
- v —' /U
B BICUCULLINE
C STRYCHNINE
The effects of strychnine and bicuculline on the 
inhibition of antidromic invasion of Deiters’ neurones 
by GABA and glycine. A. The first, third and fifth 
responses labelled "C" are field potentials produced by 
the antidromic invasion of Deiters’ neurones. The second 
and fourth responses are the same field potentials during 
the ejection of GABA (35 n A ) and glycine (25 n A ) 
respectively. B and C. As for A but during the electro­
phoretic ejection of bicuculline (70 nA for 90 secs.) 
and strychnine (20 nA for 80 secs.) respectively.
D. Following the cessation of ejection of these alkaloids
91
invasion of Dexters' neurones by stimulation of the 
ipsilateral vermis of the anterior cerebellum. In 
agreement with anatomical (Brodal, Pompeiano and Wal- 
berg, 1962) and physiological (Ito and Yoshida., 1964)
evidence, dorsaily situated Deiters' neurones were 
those most commonly inhibited in this way. In each 
experiment the conditioning-test volley interval and 
the implanted cerebellar electrode, were selected which 
gave satisfactory inhibition of the antidromic invasion 
of a Deiters' neurone with the lowest stimulus intensity 
(usually of the order of 5-10 V, 0.2 msec square wave 
stimulus). Intracellular studies (Ito, Obata and 
Ochi, 1966) have revealed an early (0.9-1.5 msec latency) 
and a larger and later inhibitory potential (1.5-9 msec, 
latency) in Deiters' neurones in response to such stimu­
lation, potentials which correspond to direct stimu­
lation of Purkinje cell axons and the subsequent ortho­
dromic activation of Purkinje cells by impulses in mossy 
and climbing fibres. In accordance with these findings 
it was not uncommon to observe early and late phases 
of .inhibition.
This inhibition of Deiters' neurones was abolished 
by electrophoretically administered bicuculline in 6 of 
7 cells tested. Intravenous bicuculline (0.1 to 0.2 
mg/kg) gave similar results with all four cells tested. 
Figure 28 illustrates the effect of electrophoretically 
administered bicuculline on the cerebellar inhibition 
of antidromic invasion of a Deiters' neurone. The 
antidromic stimulus was timed at three intervals after 
the cerebellar stimulus to reveal a period of early 
inhibition (A) followed by a period of no detectable 
inhibition (B) and then a period of late inhibition (C). 






The effect of electrophoretically administered 
bicuculline on the inhibition of a Deiters’ neurone by- 
impulses from the anterior cerebellum. The stimulus to 
the anterior cerebellum preceded that to the vestibulo 
spinal tract by three increasing intervals in A , B and 
C respectively. Inhibition of antidromic invasion is 
present in A and C. D,E and F are corresponding records 
obtained during the ejection of bicuculline (150 nA).
G, H and I were observed immediately after the cessation 
of bicuculline ejection; J,K and L a further 3*5 mins.
later.
A B
The effect of intravenous bicuculline on the 
inhibition of a Deiters' neurone by impulses from the 
anterior cerebellum. A stimulus to the vestibulospinal 
tract produced the action potential superimposed on a 
field potential shown in A while B illustrates inhibition 
of these potentials by a preceding stimulus to the anterior 
cerebellum. C and D are corresponding records obtained 
1 min. after intravenous bicuculline (0.2 mg/kg); E and F 
12.5 minutes after this initial dose. G and H were 
observed 1 min after a second dose of intravenous 
bicuculline (0.2 mg/kg).
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the early phase of inhibition within 3 1/2 minutes (D) 
but 4 1/2 minutes were required before the late inhibi­
tion was suppressed (I). This finding is in accordance 
with the relative sizes of the inhibitory potentials 
observed in intracellular studies (Ito et al. , 1966) ,
the later one being the larger. Recovery of inhibition 
at both intervals is depicted in (J) and (L), that of 
the late inhibition being observed earlier than that 
of the shorter latency inhibition.
The effect of intravenous bicuculline is shown in 
Fig. 29. The control antidromic field (A) was reduced 
in amplitude and a superimposed action potential (A) was 
inhibited by a preceding stimulus to the cerebellum (B). 
One minute after bicuculline (0.2 mg/kg) was administer­
ed intravenously this inhibition was completely blocked 
(D) , the control response (C) being unchanged. Partial 
recovery of cerebellar inhibition was seen 12.5 min 
after the first dose of bicuculline (F), and a second 
dose (0.2 mg/kg) immediately blocked the inhibition 
again. The control response (G) after this second 
dose of bicuculline shows an increased background firing 
of the neurone, and as this per se would diminish the 
effect of inhibitory impulses, less emphasis is placed 
on the significance of these results than on those o b ­
tained with bicuculline administered electrophoret- 
ica 1l y .
(iii) Thaiamus
(a) Bicuculline and the action of depressant amino 
acids
Cells of the nucleus ventralis postero-lateralis 
(VPL) and nucleus ventralis postero-medialis (VPM) 
usually fired irregularly in response to the continuous 
administration of an excitant amino acid (Andersen and
Curtis, 1964), and with the resultant varying basal 
level of firing, this limited the number of technically 
satisfactory results obtained in a study of the action 
of bicuculline on depressant amino acids administered 
electrophoretically. With 4 of 6 cells however, bi- 
cuculline administered with currents 5 to 10 times those 
of GABA reduced or abolished the action of the latter 
amino acid without affecting that of glycine. In the 
remaining two cells the action of neither amino acid 
was affected by the amounts of bicuculline used. Gly­
cine was a less potent depressant than GABA, currents 
between 1.5 and 2 times those of GABA being required 
to produce comparable depression of firing. In the 
three cells tested, amounts of electrophoretically ad­
ministered strychnine which abolished the action of 
glycine were without effect on that of GABA.
3-alanine was a less potent depressant than either 
glycine and GABA. In the two cells in which technically 
satisfactory results were obtained, both strychnine and 
bicuculline administered electrophoretically in doses 
adequate to block the action of glycine and GABA re­
spectively reduced, but did not abolish, the action of 
3-alanine.
Figure 30 illustrates results obtained from one 
cell of the VPL nucleus. This cell fired spontaneously 
at a rate of 30 to 40 spikes per second. Electrophor­
etic administration of glycine (20 nA), GABA (10 nA) 
and of 3-alanine (30 nA) reduced the firing rate as 
shown in A. During the electrophoretic administrati on 
of bicuculline (150 n A ) , Fig. 30 B, the action of GABA 
was almost completely suppressed, that of 3-alanine 
slightly reduced but that of glycine was unchanged.
Fig. 30 C, shows responses one minute after the cessa­
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The effect of the electrophoretic administration 
of bicuculline upon the response of a spontaneously firing 
thalamic neurone to glycine, GABA and ß-alanine.
A: before; B; 1 min. after commencement of bicuculline 
administration; C: 1 min. after cessation of the 
bicuculline current.
94
of GABA and 3-alanine.
(b) Bicuculline and the pattern of firing of thalamic 
cells
Two patterns of firing were observed in the re­
sponses of thalamic relay neurones to peripheral nerve 
stimuli. Most commonly an initial short latency re­
sponse was followed by a series of bursts of firing 
interupted by silent periods, the frequency of bursts 
being approximately 10/second. These silent periods 
apparently reflect prolonged inhibitory postsynaptic 
potentials, for which a recurrent inhibitory mechanism 
has been proposed (Andersen and Eccles, 1962) . The 
other,uncommon, pattern of firing consisted of a single 
burst of firing, followed by a total absence of firing 
(silent period or pause) and then a gradual return to 
the basal level.
With cells responding with 10/second bursts to a 
peripheral stimulus, bicuculline did not change the 
earliest evoked response, but the first pause in firing 
was lengthened and later bursts of firing were reduced 
or abolished. If the initial firing rate (whether 
spontaneous or DLH-mduced) was high, there was an earl­
ier return to it. Fig. 31 A is composed of post-stimu­
lus histograms compiled by a computer from one such cell. 
The control response, 1, shows an initial burst above 
an arrow marking the position of the stimulus, which 
preceded this initial burst by 4 msec, followed by two 
further bursts separated by silent periods, and then 
continual low frequency firing to the end of the sweep 
(approx. 800 msec after the stimulus), at which time the 
mean frequency was about 50% of the control level.
DLH was administered continuously to this cell and 








The effect of bicuculline on the patterns of 
firing of single thalamic neurones. A computer summed 
the responses in 256 intervals each of Z* msec. Peripheral 
nerves were stimulated at the time of the arrows and 
vertical dotted lines. A: median nerve stimulation, 50 
summed responses. 1 — before; 2 - 13 min. after start 
of electrophoretic administration of bicuculline (150 nA); 
3 — 24 min. following cessation of the ejection of bicucu— 
lline. B: ulnar nerve stimulation, 100 summed responses.
1 — before; 2 - 9  min. after i.v. bicuculline, 0.2 mg/kg;
3 — 11 min. later.
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filing rate before, during and after the administration 
of bicuculline. Fig. A2 shows that after the electro­
phoretic administration of bicuculline, 150 nA for 13 
min, the initial burst was unaltered, but was followed 
by a long absence of firing and there were no subse- 
quent bursts. Figure 31 A3 depicts recovery of the 
firing pattern 4 mins after cessation of the bicuculline 
ejecting current.
Results similar to these were observed in three of 
five cells when bicuculline was administered electro- 
phoretically, the other two showing no change in firing 
pattern. Similar results were obtained by giving bi­
cuculline intravenously, as illustrated in Fig. 31 B.
The basal firing rate of this cell was also maintained 
constant by a varying amount of DLH. The control re­
sponse, 1, shows four bursts of firing following the 
peripheral nerve stimulus. Within 2 minutes (the hi­
stogram was recorded at 9 minutes) of administering bi­
cuculline 0.2 mg/kg i.v. the initial burst was unaltered 
but was followed by a single prolonged pause and then 
a gradual return to near pre-stimulus levels by the end 
of the sweep. Fig. 31 B3 depicts partial recovery 
20 mins after the intravenous dose, with a return to 
"burst like" firing. The two cells studied in this 
manner gave identical results. Results from several 
other cells were technically unsatisfactory because of 
differences in the basal level of firing before and 
during the administration of bicuculline.
Four cells showed the second pattern of firing, an 
initial response, a prolonged pause and then a gradual 
return to the basal level. With only one of these was 
the basal level of firing constant and this showed no 















The action of i.v, bicuculline upon the inhibition 
of a thalamic neurone elicited by preceding afferent 
impulses* Peroneal nerve stimulations Abscissa: 
interval between conditioning and testing stimuli. 
Ordinate; per cent inhibition of response to testing 
stimulus. Open circles: control; crosses: 2 min. after 
0.1 mg/kg of bicuculline; closed circles: 2 min. after 
a second dose of 0.1 mg/kg administered 6 min. following
the first.
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An analysis was also carried out of the effect of 
bicuculline on the inhibition of the shortest latency 
discharge produced by a preceding stimulus delivered to 
the same peripheral nerve. The intensity of the test­
ing stimulus was reduced so that only 2 or 3 action 
potentials were evoked, and the preceding inhibitory 
volley further reduced so that on average it elicited 
only a single action potential. This had the effect 
of reducing the inhibitory postsynaptic potential which 
followed the initial evoked discharge, thereby making 
it more susceptible to the action of a possible anta­
gonist of the inhibitory transmitter. The inhibition 
was observed at three time intervals and at each the 
response to 40-50 trials were averaged. Inhibition 
curves could thus be plotted relating the volley inter­
val to the response to the second volley expressed as 
a percentage of the control response observed in the 
absence of the first stimulus.
Fig. 32 illustrates a number of inhibitory curves 
compiled in this manner, and shows a marked reduction 
in the maximal inhibition by one dose of bicuculline, 
0.1 mg/kg I.V., and a further but lesser reduction 
following an additional dose of 0.2 mg/kg I.V. Both 
cells studied in this manner gave similar results when 
bicuculline was administered intravenously, but with 
only one of four cells was this effect observed follow­
ing the electrophoretic administration of bicuculline.
DISCUSSION
Convulsants may directly excite neurones or interfere 
with the action of inhibitory impulses impinging on them.
When administered electrophoretically, bicuculline was a 
weak excitant of neurones as measured by an increase in spon­
taneous firing or in the sensitivity to an excitant amino 
acid. This effect may have been caused by a blockade of 
tonically active inhibitory impulses as it was more marked 
in areas where bicuculline sensitive inhibition was demon­
strated, (for example in Deiters' nucleus), and minimal 
in the spinal cord where the inhibitions tested were not 
reduced by bicuculline. The potency and rapidity of bi- 
cucullme as a convulsant (0.2-0.6 mg/kg) when administered 
to cats is such that the weak delayed excitation observed 
in microe1ectrophoretic.experiments is unlikely to be the 
basis for its convulsant action. It seems probable then, 
that bicuculline interferes with the operation of inhibitory 
synapses .
The speed with which bicuculline reduces inhibition 
probably excludes an interference with the synthesis of an 
inhibitory transmitter. An interference with the release 
of transmitter cannot be excluded but is rendered unlikely 
by antagonism of the postsynaptic action of GABA by bicu- 
culline and the body of other evidence discussed previously 
which suggests that GABA is a transmitter at certain central 
inhibitory synapses. Structural considerations (Curtis, 
Duggan, Felix and Johnston, 1970) have indicated certain 
similarities between the molecules of bicuculline and GABA 
which are consistant with the view that these substances may 
compete for the same receptor.
Specificity of action is the important factor to be 
determined if bicuculline is to be considered as a useful
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aid in the identification of synapses at which GABA is the 
inhibitory transmitter. The division of amino acids into 
two groups on the basis of antagonism by bicuculline agrees 
with that made on the basis of antagonism by strychnine 
(Curtis et al . , 1968a) , when considering depression of fir­
ing of spinal neurones.
With supraspinal neurones however, the depressant 
effects of 3-alanine and taurine, both "glycine like" amino 
acids in their action on spinal neurones, are reduced by 
bicuculline. This has been demonstrated for 3-alanine in 
the cerebral cortex (Curtis et al., 1970), thalamus, Deiters' 
nucleus and hippocampus (Curtis, Felix and McLennan, 1971) 
and for taurine in the cerebral cortex (Curtis et al., 1970).
The action of strychnine on depressant amino acids in supra­
spinal regions is also varied. Strychnine blocks the act­
ion of glycine and 3 - a l a n m e  but not that of GABA on cere­
bral cortical neurones (Curtis et al., 1967); Krnjevic et al., 
1968), reduces the action of glycine, GABA and 3-alanine on 
hippocampal neurones (Curtis, Felix and McLennan, 1971) , 
blocks the action of glycine, reduces the action of 3-alanine 
but has no effect on that of GABA on thalamic neurones, and 
blocks the action of glycine but not that of GABA and has 
little if any effect on the action of 3-alanine on Deiters 
neurones. 3-Alanine is intermediate between glycine and 
GABA in the series of aliphatic unbranched u-amino acids, 
and hence could possibly interact with both glycine and GABA 
receptors. According to the relative numbers of each type 
of receptor, the effects of 3 -alanine could thus be blocked 
by either strychnine or bicuculline, but a complete explana­
tion would require a knowledge of the affinity of 3-alanine 
for each receptor. A similar explanation can be applied 
to taurine, an amino acid in which a sulphonic group re­
places the carboxyl group of 3-alanine.
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Thus of the substances tested, bicuculline was an anta­
gonist of the action of GABA, 3-hydroxy GABA, 6-amino valeric 
acid, muscimol, and imidazole acetic acid on spinal neurones, 
and to this list must be added 3-alanine and taurine when 
considering certain supraspinal neurones. Hence bicuculline 
is not a specific antagonist of the action of GABA. Anta­
gonism by bicuculline however does not identify GABA as the 
transmitter at a particular synapse; such antagonism is only 
part of a body of evidence. Of the substances the action of 
which is antagonized by bicuculline only GABA, taurine and 
3-alanine occur in mammalian brain (Tallan, 1962; Himwich and
Agrawal, 1969) . In addition, imidazole acetic acid has been
3found to be the major metabolite of H histamine given intra- 
ventricu1arly to the rat (Snyder, Glowinski and Axelrod,
1969), although little of this substance is formed after the 
intraventricular administration of histamine to the cat 
(White, 1960) . 3-HydroxyGABA, despite earlier claims of its
presence (Ohara, Sano, Koizumi and Nishinuma, 1959) has not 
been detected using isotope dilution techniques (Mitoma, 1960)
The failure by bicuculline to affect certain spinal 
postsynaptic inhibitions, which are sensitive to strychnine 
(Bradley et al., 1953; Curtis, 1962), supports previous pro­
posals that glycine is the inhibitory transmitter at these 
sites (Curtis et al. , 1968a,b) . However, GABA has marked
inhibitory effects on spinal neurones (Curtis, Phillis and 
Watkins, 1959) and is present in spinal tissue in appreciable 
amounts (Graham et al. , 1967) , suggesting that this substance
may be a transmitter at spinal inhibitory pathways as yet 
undefined.
When considered with the other evidence implicating 
GABA as the inhibitory transmitter of Purkinje cells, the 
demonstration that bicuculline blocks both the inhibition of 
Deiters neurones by impulses from the anterior cerebellum
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and the action of GABA upon these cells, constitutes a strong 
argument for GABA being the transmitter released by the ter­
minals of Purkinje cells onto Deiters neurones.
Within the thalamus, claims have not been made for any 
substance as the transmitter mediating the inhibitory post- 
synaptic potential that follows activation of relay neurones. 
The observation illustrated in Fig. 32 indicates that this 
inhibitory potential is considerably attenuated by bicucull- 
ine, and hence that GABA, or a substance also blocked by bi- 
cuculline, may be the transmitter at this synapse. The 
other evidence, both neurochemical and neurophysiological 
which is needed for transmitter identification is lacking in 
the thalamus, and hence the claim that GABA may be an inhi­
bitory transmitter is a tentative one.
Attenuation of this inhibitory postsynaptic potential, 
which is believed to be generated by a recurrent inhibitory 
mechanism (Andersen, Eccles and Sears, 1964) , may explain 
the seemingly paradoxical observation of Fig. 31, in which 
the pause in firing which follows the initial activation of 
neurones was prolonged by bicuculline. One explanation 
that has been offered to account for the restitution of firm­
ing following a period of inhibition is "post-anodal exalta­
tion" (Andersen et al. , 1964) , a "rebound" excitation after
a period of intense depression. The magnitude of a burst 
of firing so produced may be a function of the intensity of 
the preceding hyperpolarization, as demonstrated in the 
hippocampus (Kandel and Spencer, 1961) and smooth muscle 
(Bennett, 1966). Thus a reduction in the inhibitory post­
synaptic potential by bicuculline could abolish the "re­
bound" firing, and the first period of inhibition would then 
represent the full time course of the reduced IPSP , uncom­
plicated by interposed bursts of firing.
Purpura and Cohen (1962) recorded EPSP-IPSP sequences 
in neurones of the thalamic nucleus ventralis lateralis
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in the absence of cell firing, and the importance of post- 
anodal exaltation in synchronizing thalamic cells during 
recruiting responses has been questioned (Purpura, Frigyesi, 
McMurty and Scarff, 1966). If it is assumed that the bursts 
of firing following each pause are the result of a process 
of disinhibition, then the effect of bicuculline in abolish­
ing these bursts can also be explained. This concept is 
illustrated in Fig. 33.
The cell labelled TI tonically inhibits the relay neu­
rone TCR. Activation of cell TCR results in recurrent in­
hibition via cell R I , a collateral of which also inhibits 
the cell T I . Thus the phase of recurrent inhibition would 
be succeeded by excitation. As the pause following the 
initial burst of firing is long (70-100 msec), the pathway 
to the cell TI would need to be polysynaptic and/or the in­
hibitory cell TI fire repetitively. If both inhibitory 
synapses on the TCR cell were mediated by GABA, both would 
be sensitive to bicuculline and the final pattern of firing 
would depend upon their relative sensitivities to the alkaloid 
The inhibitory postsynaptic potential produced by recurrent 
inhibition is intense (Eccles, 1966), and if this were merely 
attenuated by bicuculline and disinhibition abolished, the 
pattern of firing would be similar to that observed - a 
prolonged pause followed by a gradual return to firing with­
out bursts. If the cell TI was situated close to cell R, 
electrophoretically administered bicuculline could interfere 
with inhibition of cell T I , again making the process of 
disinhibition more susceptible to bicuculline than recurrent 
inhibition, and hence producing the pattern of firing obser­
ved .
In addition to the studies presented in this Thesis, 
bicuculline has been shown to reduce the following inhibi­
tions: the inhibition of cerebellar Purkinje cells by
Fig, 33
A proposed scheme of disinhibition in the 
ventrobasal thalamus.
TCR = Thalamocortical relay cell 
RI = Recurrent inhibitory cell 
TI = Tonically active inhibitory cell 
The axons of inhibitory cells are represented by interup- 
ted lines with unfilled triangles as their endings; 
those of excitatory cells are shown as solid lines with 
filled triangles as endings.
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basket cells (Curtis, et al. , 1970), the inhibition of hippo­
campal pyramidal cells by basket cells (Curtis, Felix and 
McLennan, 1971) , the inhibition of peri cruciate deep pyra­
midal cells by local surface stimulation and by repetitive 
stimulation of the pyramidal tract (Curtis et al. , 19 70) , and
the inhibition of olfactory bulb mitral cells by granule 
cells (Felix and McLennan, 1971). Bicuculline also blocks 
the inhibition of, and the action of GABA on, the stretch 
receptor neurone of the crayfish Eustacus armatus (McLennan, 
1970) .
Bicuculline is the first pharmacological agent to re­
duce or abolish mammalian strychnine resistant inhibitions 
in sub- and just-convulsant doses. Whilst it is not speci­
fic as an antagonist of GABA, only three of the substances 
bicuculline is known to antagonize occur in the mammalian 
central nervous system and hence this alkaloid can provide 
valuable evidence in identifying synapses at which GABA may 
be the transmitter.
It is interesting to note that all of the strychnine 
resistant inhibitions studied to date have been modified by 
the action of bicuculline, suggesting that the number of in­
hibitory transmitters used in the mammalian central nervous 
system is limited.
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VIII. THE DISTRIBUTION OF FREE AMINO ACIDS IN SPINAL 
CORD, SPINAL ROOTS, DORSAL ROOT GANGLIA AND 
PERIPHERAL NERVES
The neurochemica 1 studies of Graham et al. , (1967) are
consistant with L-glutamate being the transmitter released 
at the terminals of primary afferent fibres and L-aspartate 
as that released by spinal cord excitatory interneurones of 
the cat. Rizzoli (1968) however, in a study of glutamate 
levels in the dorsal and ventral roots of four species (rat, 
dog, rabbit and bull frog) failed to find significantly 
higher levels of glutamate in dorsal roots than in ventral 
roots in both dog and rat. That part of the dorsal root 
between ganglion and spinal cord, the part examined by 
Rizzoli ( 1968) , contains the central processes of dorsal 
root ganglion cells, and as the site of transmitter synthesis 
within this system is unknown, these studies were extended 
in the cat to include tissues containing the cell bodies and 
peripheral processes of these first, order afferent neurones. 
Other excitants of spinal neurones occur in neural tissue.
For example cysteate and cysteine sulphinate, excitants com­
parable in strength with glutamate (Curtis and Watkins, 1960) , 
have been found in normal rat brain (Mussini and Marcucci, 
1962; Bergeret and Chatagne, 1954), and it seemed necessary
to extend regional distribution studies to include these 
amino acids. The levels of free a m m o  acids in dorsal and 
ventral roots of the dog and rat was also examined.
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RESULTS
{i) Free amino acids in cat spinal roots dorsal root ganglia 
and peripheral nerves
Complete amino acid analysis of the picric acid extracts 
of the ventral roots and the dorsal roots between ganglia and 
cord revealed 16 major (i.e. more than approximately 0.1 
ymole/g wet tissue) ninhydrin-positive peaks. These were, 
in order of elution from the column: 1-4, complex mixtures
of phosphorylserine,phosphorylethanolamine, glyeerylphos- 
phorylcholine and glycerylphosphorylethanolamine (Mangan and 
Whittaker, 1966), together with lesser amounts of cysteate and 
cysteine sulphinate; 5, taurine; 6, urea; 7, aspartate;
8, threonine; 9, serine; 10, glutamine; 11, glutamate; 12, 
glycine; 13, a-alanine; 14, ethanolamine; 15, ammonia; 16,
lysine. Of the known excitant amino acids, only aspartate 
and glutamate were found in relatively high concentrations.
The levels of cysteate and cysteine sulphinate in the spinal 
root extracts were estimated to be less than 1.0 ymole/g by 
thin layer chromatography, and no significant dorso-ventra1 
differences were observed. Glutamate was the only one of 
the 16 major ninhydrin-positive compounds significantly more 
concentrated in extracts of dorsal roots than in extracts 
of ventral roots.
Five amino acids - aspartate, glutamine, glutamate, 
glycine and a-alanine - accounted for more than 80% of the 
total ninhydrin-positive material excluding the phospholipids, 
urea and ammonia in the spinal root extracts. The concen­
trations of these amino acids in extracts of the various 
regions of nervous tissue examined are listed in Table 3. 
Ventral roots, dorsal roots peripheral to ganglia, and the 
peripheral nerves of both muscular and cutaneous type were 
similar in amino acid content, whereas dorsal root ganglia 
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Glutamate levels were disproportionately high in dorsal 
roots between ganglia and cord,Fig. 34, when compared with 
those of the other amino acids in all other tissues examined 
Within this region of the dorsal roots only glutamate was 
significantly (P<0.02, Student's t-test) less concentrated 
(Fig. 34), in that half closer to the cord.
(ii) Free amino acids in dorsal and ventral roots of dog 
and rat.
Table 4 gives the levels of the five major amino acids 
in the dorsal and ventral roots of cat, dog and rat. Gluta 
mate was the only amino acid in significantly higher concen­
tration in dorsal than in ventral roots.
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DISCUSSION
The nerve fibre content of the tissues which were com­
pared is as follows :-
1. Dorsal roots between ganglia and cord contain only
the central processes of cells found in the dorsal root gan­
glia, all types of sensory fibres being represented: cutan­
eous, autonomic, and afferents from muscle and joints. The 
number of ganglion cells displaced into the dorsal roots is 
negligible (Peters, 1935; Stacey, 1969).
2. Dorsal roots peripheral to ganglia contain the 
peripheral processes of dorsal root ganglion cells. These 
fibres are of a slightly greater diameter than their central 
counterparts (Cajal, 1909; Gasser, 1954) and it has been 
suggested that there is multiple branching of the unipolar 
cells with more branches directed centrally (Gasser, 1954; 
but see Tennyson, 1965). Electron micrographs of dorsal 
roots close to ganglia show greater amounts of "empty space" 
within the Schwann cell sheaths of the non-medullated fibres 
when compared with cutaneous nerve (Gasser, 1954).
3. Dorsal root ganglia contain neurones, the single 
processes of which divide into central and peripheral pro­
cesses .
4. Cutaneous nerves contain the peripheral processes 
of cell bodies found in dorsal root ganglia, both cutaneous 
and autonomic, plus postganglionic autonomic efferents.
Very few fibres remain in cutaneous nerve after removal of 
the appropriate dorsal root ganglia (Boyd and Davey, 1968) , 
and these autonomic efferents are likely to be only a minor 
component of cutaneous nerves.
5. Muscle nerves contain efferent fibres, both somatic 
and autonomic, and proprioceptive and autonomic afferents.









Diagrammatic representation of the levels of free 
glutamate in ujnol/g wet tissue, in the lumbosacral spinal 
cord, dorsal and ventral roots, dorsal root ganglia and 
peripheral nerves of the cat. The spinal levels are those 
of Johnston(1968) .
107
ganglia and the various regions of the dorsal roots are 
directly comparable. The transition from ganglia to dorsal 
roots on either side of the ganglia is associated with an 
abrupt fall in the levels of aspartate, glutamine, glycine, 
and a-al a n m e  to approximately the levels of these amino 
acids found in the samples of peripheral nerves. While 
this is also true for glutamate levels in dorsal root gan­
glia and peripheral dorsal root, the levels of this amino 
acid fall in a more gradual fashion from ganglia towards 
to cord, as illustrated in Fig.34, such that the glutamate 
levels in the dorsal root samples close to the cord remain 
significantly in excess of those found in the samples of 
peripheral nerves.
In the dog, glutamate was the only amino acid found in 
uniformly high concentrations in dorsal root ganglia, and 
in dorsal roots between ganglia and cord, all other amino 
acids being found in much higher concentrations in ganglia 
than in dorsal roots. The glutamate gradient along the 
dorsal roots of the cat was not observed in the dog, the 
glutamate levels in the dorsal root samples close to the 
cord being not significantly different from those in the 
dorsal root ganglia (Duggan and Johnston, 1970; and unpub­
lished) .
The present results are consistent with the proposed 
role of glutamate as an excitatory transmitter at the ter­
minals of primary afferent fibres (Graham et al. , 1967) .
The failure to confirm the results of Rizzoli (1968) re­
moves one objection to this proposal. The glutamate levels 
of approximately 2 ymole/g in the peripheral nerves, peri­
pheral dorsal roots and ventral roots may be that required 
for various metabolic functions, while the glutamate in 
excess of these levels may be associated with that released 
from nerve terminals in the spinal cord. It is unlikely
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that the "excess" glutamate in these dorsal roots results 
from local synthesis in view of the close similarity of dor­
sal and ventral roots with respect to g 1utamate-metabo1ising 
enzymes (Graham and Aprison, 1969) and their nitrogen-con­
taining substrates (ammonia, aspartate, glutamine and ot-ala- 
nine). The high dorsal root levels of glutamate are more 
likely to result from synthesis in dorsal root ganglia and 
subsequent transport towards the spinal cord. There is 
good evidence for the axonal transport of specific substan­
ces from the soma towards the nerve terminals elsewhere in 
the mammalian nervous system, (Barondes and Samson, 1967; 
Lasek, 1968; S]ostrand, 1969), and for the axonal trans­
port of glutamate in frog and snail nerves (Kerkut, Shapira 
and Walker, 1967) .
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